Etiological Profile of Macrocytic Anemia in Patients  Admitted in PSG Hospitals by Yoganathan, C
                                                     
                                                                April 2015 
 
  
                ETIOLOGICAL PROFILE OF MACROCYTIC ANEMIA IN PATIENTS  
                                                     ADMITTED IN PSG HOSPITALS                        
 
                                                                        By 
 
                                                           Dr. Yoganathan. C 
 
                                                    Dissertation submitted to the  
 
                                  Tamil Nadu Dr. M.G.R Medical university, Chennai 
 
                             In partial fulfilment of the requirements for the degree of 
 
                                            Doctor of Medicine in General Medicine 
 
                                    
 
    
                                                               
 
 
 
                                                           Under the guidance of 
 
                                                       Professor Sujithkumar. S M.D 
 
                                                    Department of General Medicine 
 
                                   P.S.G Institute of Medical Sciences & Research, Coimbatore 
 
                                        Tamil Nadu Dr. M.G.R Medical university, Chennai 
 
 
 
  
                                                     
 
     
                                           CERTIFICATE BY THE GUIDE 
 
 
 
 
This is to certify that the dissertation entitled, “ETIOLOGICAL PROFILE OF 
MACROCYTIC ANEMIA IN PATIENTS ADMITTED IN PSG HOSPITALS” is the 
bonafide original work of Dr. YOGANATHAN. C in partial fulfilment of the requirements 
for  the degree  of   Doctor   of   Medicine  in  General  Medicine 
 
 
 
 
 
 
 
 
                                                                                    Signature of the guide 
                                                                                                           Dr. Sujithkumar. S  MD 
                                                                                                          Professor of Medicine 
                                                                                                Department of General Medicine 
                                                                                                       P.S.G IMSR, Coimbatore 
                              
 
 
 
                                 
 
 
 
 
 
 
 
                               
  
                                                     
ENDORSEMENT BY THE HOD, PRINCIPAL / HEAD OF THE INSTITUTION    
 
 
 
This is to certify that the dissertation entitled, “ETIOLOGICAL PROFILE OF 
MACROCYTIC ANEMIA IN PATIENTS ADMITTED IN PSG HOSPITALS” is the 
bonafide original research work of Dr. Yoganathan. C under the guidance of                      
Dr. Sujithkumar. S MD, professor of Medicine, P.S.G IMSR, Coimbatore  in partial 
fulfilment of the requirements for the degree of Doctor of Medicine in General Medicine. 
 
 
 
 
 
 
 
 
 
Seal and Signature of the HOD                     Seal and Signature of the Principal 
 
Dr. Jayachandran. K MD                                        Dr. Ramalingam. S MD 
 
Professor & HOD, Department of Medicine             Principal 
 
P.S.G IMSR, Coimbatore                                           P.S.G IMSR, Coimbatore 
 
 
 
 
 
 
 
 
 
 
                                           
                                                     
DECLARATION BY THE CANDIDATE 
 
 
I hereby declare that this dissertation entitled “ETIOLOGICAL PROFILE OF 
MACROCYTIC ANEMIA IN PATIENTS ADMITTED IN PSG HOSPITALS” is a 
bonafide and genuine research work carried out by me under the guidance of                              
Dr. Sujithkumar. S  M.D, Professor of Medicine, P.S.G IMSR, Coimbatore. 
 
 
This dissertation is submitted to the Tamil Nadu Dr. M.G.R Medical University in fulfilment 
of the University regulations for the award of MD degree in General Medicine. This 
dissertation has not been submitted for award of any other degree or diploma. 
 
 
 
                                                                   Signature of the Candidate 
                                                                          Dr. Yoganathan. C 
 
 
 
 
 
                                                             
 
 
 
 
 
 
 
 
 
                                                     
COPYRIGHT DECLARATION BY THE CANDIDATE 
 
 
 
I, Dr. Yoganathan. C hereby declare that the Tamil Nadu Dr. M.G.R Medical University, 
Chennai shall have the rights to preserve, use and disseminate this dissertation in print or 
electronic format for academic / research purpose. 
 
 
 
 
 
Signature of the Candidate 
Dr. Yoganathan. C  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                     
ACKNOWLEDGEMENTS 
 
 
 
It gives me immense pleasure to express my heartfelt and profound sense of gratitude to my         
respected teacher and guide, professor Dr. Sujithkumar for his valuable suggestions, 
meticulous guidance, support and encouragement in doing this study. 
 
I am grateful to professor and head of the department Dr.Jayachandran, professor  
Dr.L.Somasundaram, professor Dr.Sujaya menon and professor Dr.Saravanan for their 
invaluable help in preparing this dissertation. I would like to thank my associate professors 
Dr.Tolstoy, Dr.Denesh narasimhan , Dr.Anithkumar and Dr Jagadeeswaran for their support. 
I am also grateful to assistant professors Dr.Sathish, Dr.Santni, Dr.Vellammal, 
Dr.Mohammed zia ansari , Dr.Anuja and Dr.Krishnaprasad for their guidance. 
 
I am grateful to Dr.Suwetha, Associate professor, department of community medicine who 
helped me with the analysis of the data. 
 
I am thankful to Miss.Vijayalaksmi and Miss.Kavitha, Secretaries, Department of General 
Medicine for their support. 
 
I would also like to extend my gratitude to the entire Department of Medicine for all the 
support throughout my course in General Medicine. 
 
I am grateful to my family members for their moral support and encouragement throughout 
my  studies. 
 
                                                     
 
                                                     
 
  
                                                     
TABLE OF CONTENTS 
 
SL. NO TOPIC PAGE NO. 
1. INTRODUCTION  01 
2. AIMS AND OBJECTIVES                                                                                                                    02
3. REVIEW OF LITERATURE                                                                                03
4. MATERIALS AND METHODS 76 
5. RESULTS                                                                                                            78 
6. DISCUSSION                                                                                                        97
7.  LIMITATIONS OF THE STUDY                                                                                                    110 
8. CONCLUSIONS AND RECOMMENDATIONS 111 
9.  REFERENCES                                                                                                 113 
10. APPENDIX       120 
 
  
                                                     
LIST OF TABLES 
 
Table No. Tables Page No. 
1  Small bowel mucosal histology in various  malabsorptive disorders     31 
2  Symptoms of malabsorption     32 
3   MCV Vs RDW     38 
4  Stage of Maturation  – by  Heilmiyer     42 
5 
Effects on numbers of counted RBCs over the error in statistics 
reticulocyte count.  
    45 
6 Comparison of reticulocyte parameters      47 
7 
Association of HcT with the maturation time of reticulocytes in 
periphery 
    49 
8 Interpretating the  value  for RPI     50  
9 Maturation stages of reticulocytes     51 
10  Color taken up by different cellular components and inclusions     60 
11 Cell composition of adult bone marrow aspirate     62 
12 Sex distribution     78 
13  Age distribution      78 
14 Presenting symptoms     80 
15  Hematological parameters     83 
                                                     
16 
 Sex distribution in patient presenting as  pancytopenia and 
bicytopenia 
    84 
17  Hematological parameter in patients with bicytopenia     84 
18  Hematological parameter in patients with pancytopenia     85 
19 Mean MCV and degree of anemia     85 
20 Level of vitamin B12 and MCV     86 
21 
Level of vitamin B12 in patients with pancytopenia,bicytopenia and 
anemia 
    86 
22 
Megaloblastic features in peripheral smear  and megaloblastic bone 
marrow 
    90 
23  Positive duodenal endoscopic findings and tropical sprue     93 
24 Gender distribution in tropical sprue     95 
25 Causes of Macrocytic anemia in various studies     97 
26 Gender distribution in various studies    100 
27 
Comparison of hematologic parameters of the study population at 
presentation 
   104 
28  Comparision of hematological parameters    104 
29 Comparison  of  haemoglobin and Mean corpuscular volume     105 
30 Comparison of peripheral smear findings    108 
 
 
 
                                                     
1 
 
INTRODUCTION 
 
Macrocytosis is common in various clinical settings and it is found in approximately  1.7–
3.6% of people admitted for  care for any cause
1,2,3
. Macrocytosis would be seen even in the 
absence of anemia. Heterogeneous group of disorders acting via various known and 
unkwown processes can lead to macrocytic anemia. Macrocytic anemia is generally classified 
as megaloblastic or non-megaloblastic anemia. Disorders that affect the synthesis of DNA in 
the precursors of erythrocytes leads to megaloblastic anemia and other disorders through 
various processes causes non-megaloblastic anemia. 
 
Often we see macrocytosis preceding anemia
4,5,6
, which is  usually  not investigated, 
particularly when anemia is very mild. Vitamin B12 deficiency may perhaps produce only 
low grade macrocytic anemia which when persistant for a prolonged duration there is a rapid 
detoriation, which has been demonstrated in various case studies. Patient might present with 
similar symptoms irrespective of the cause for anemia. An increased value of MCV, among 
various other  findings at regular laboratory investigations, might  be the early  feature of  
various disease states like low vitamin B12 or  low folate levels, pre leukemia, drug induced 
or alcoholism
7
. Macrocytic anema would be wrongly diagnosed as iron deficiency anemia in 
many of the situations because of similar presentation of variety of anemias. When there is no 
response to iron supplementation after a latent period then only the diagnosis of 
megaloblastic anemia is offered. Suspicion at high level, properly eliciting the history and 
thorough examination of the patient will lead us in diagnosing macrocytic anemia. To search 
for and identification of distinct clinical features may help to diagnose megaloblastic anemia 
and also may help in the early identification of low levels of B12 or folic acid. 
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AIMS AND OBJECTIVES 
 
 To identify the etiology of macrocytic anemia in patients presenting to tertiary care 
hospital in South India (PSG Hospitals). 
 To evaluate the causes for megaloblastic anemia. 
 To evaluate utilization of bone marrow examination and upper GI endoscopy in 
diagnosis of megaloblastic anemia. 
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REVIEW OF LITERATURE 
 
Anemia in humans have been classified on determining the mean corpuscular volume (MCV) 
of the red blood cells
8
. The size of the red blood cells is indicated by Mean corpuscular 
volume. Upon determining the MCV various pathologic processes might me thought and few 
others could be excluded. Electronic cell counters which determines the various parameters 
of the cells in the blood has made the MCV as a useful and integral part of the red cell 
profile
1,2
. MCV is the value of average volume of the red cells calculated by the coulter 
counter. It is not only used to classify anemia but also to identify the reason for low 
hemoglobin. Normal range of MCV is between 78 fl and 94 fl. If a patient has low 
hemoglobin and MCV of lower  than 78 fl  then he is diagnosed to have  microcytic and if it 
is higher  than 95 fl  he is diagnosed to have  macrocytic
3 
anemia. Since  lack  of  either folic 
acid  or  vitamin B12  disrupts  the maturation process  and causes  megaloblastic changes in 
the  precursor cells,  deficiency of either of the  vitamins  produces same symptoms. The 
commonest cause of cobalamin deficiency is malabsorption. Inadequate intake through 
dietary source would be the other only cause. Vitamin B12 deficiency may also result if there 
is surgical removal of the stomach leading to non-availability of intrinsic factor or ileum 
leading to non-availability of absorptive surface
7,9,10
. Intestinal stagnant loop syndrome, 
diverticulosis of jejunum, ileocolic fistula and intestinal strictures may lead to cobalamin 
mal-absorption thereby causing deficiency. Infestation of the intestine with worms may lead 
to cobalamn deficiency particularly fish tape worm. Other common mal-absorptive cause is 
Tropical sprue seen in tropical region. Pure vegetarians are prone to Vitamin B12 deficiency 
than non-vegetarians. Children born to mothers with B12 deficiency are more prone and 
would develop B12 deficiency  within about  three to six  months because of  lower storage 
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levels. Congenital deficiency of intrinsic factor  causes Pernicious anaemia  a peculiar type of 
megaloblastic anaemia
9
.  
 
Folic acid deficiency is the most common vitamin deficiency disease which leads to 
megaloblastic anemia. Folate deficiency occurs commonly in the extremes of age i.e. in 
infancy and old age. Poor dietary intake occurs in patients in poverty, associated with scurvy 
and kwashiorkor. Mal-absorptive syndromes like Tropical sprue, gluten induced enteropathy 
may cause folate deficiency. Because of increased demand, associated with pregnancy, 
growing children and in people with haemolytic anaemias deficiency of folic acid occurs. 
 
The presenting features of patients with megaloblastic anemia like anorexia, irritability and 
easy fatiguability are due to anemia. Other symptoms like loss of weight, diarrhea or 
constipation could be present. Distinct clinical  findings associated with  megaloblastic 
anemia are reversible hyperpigmentation, angular cheilosis and glossitis
11
. There may be 
enlargement of liver and spleen and sore tongue. Severely anemic patient may present with 
mild fever and jaundice. Associated low platelet count and low leucocyte count leads to 
bleeding tendencies and infections as the presenting symptoms. 
 
Deficiency of vitamin B12 causes symmetrical peripheral polyneuropathy, loss of myelin in 
the spinal cord particularly involving the posterior column and pyramidal tracts. Neurological 
features seen in Vitamin B12 deficiency are parasthesia in fingers and feet, memory loss, 
poor gait, loss of position sense, psychiatric disturbances, blindness and optic atrophy. Folic 
acid deficiency  do not produce  neurological symptoms
12
. 
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Peripheral blood smear in early stage before producing anemia may show only few 
macrocytes and hypersegmented neutrophils. Later stages show oval macrocytes, 
anisocytosis and poikilocytosis. Reduction in total leucocyte and platelet counts are noted in 
parallel to the degree of anemia. 
 
Bone marrow is hypercellular. The erythroblast nucleus maintains a primitive feature. The 
cell size would be of greater than normoblasts and there might be more number of cells with 
eccentrically placed nuclei with lobulations or nuclear fragments might be seen. The other 
characteristic features are enlarged and differently shaped metamyelocytes and large sized 
hyperploid  megakaryocytes. 
 
Macrocytosis with increased MCV is seen in chronic immune mediated haemolytic 
anaemia
13
. It is due to an increase in reticulocyte count. Bone marrow undergoes a 
megaloblastic change due to an increased demand of folic acid for hyperplastic 
erythropoeisis. Overall, a picture of ineffective erythropoeisis is seen which leads to 
destruction of cells causing pancytopenia. Investigations reveal elevated serum unconjugated  
bilirubin  and elevated serum LDH level. Megaloblastic anemia is associated with more 
anisocytosisis than that of non-megaloblastic anaemia. 
 
There have been many drugs that have been implicated in causing macrocytosis and they are  
cyclophosphamide, hydroxyurea, methotrexate, pyrimethamine,trimethaprim, valacyclavir 
etc. 
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In evaluation of macrocytosis microscopic examination by peripheral smear is a much more 
sensitive when compared to automated RBC indices. Automated RBC indices underestimate 
about 30 % of cases of macrocytosis when compared with peripheral smear finding. 
 
Hyperglycaemia, cold agglutinins and marked leucocytosis causes falsely elevated 
MCV
14,13,15
 
 Macrocytosis without anaemia can also be a normal variant and is noted to occur in families 
with a genetic predisposition. The common pathologic causes for macrocytosis are 
1. Drugs 
2. Alcoholism 
3. Reticulocytosis 
4. Hypothyroidism 
5. Liver diseases 
6. Low Vitamin B12  
7. Multiple myeloma 
8. Folate deficiency 
9. Myelodysplastic syndromes 
10. Acute leukemia 
11. Aplastic anemia 
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Hypersegmentation of neutrophils signifies megaloblastic “arrest” and thus impaired DNA 
synthesis. The following are the feature of hypersegmentation: 
- Any neutrophil with 6 or more lobes, 
- 5% of neutrophils with 5 lobes, 
- majority have more than 4 lobes. 
 
A lobe is considered distinct if it is separate from the nucleus or connected by a fine 
chromatin thread. It has been suggested that hypersegmentation can be most reliably detected 
by use of the segmentation index (% of neutrophils with five lobes or more, relative to the 
number of four-lobed neutrophils). 
 
Other diseases associated with Hypersegmented neutrophils are as follows: 
1. Iron deficiency anaemia
16,17
 
2. Uraemia
18
 
3. Hyperthermia
19
 
4. Myelodysplastic syndromes
20
 
5. Langerhans cell histiocytosis
21
 
6. Post irradiation
22
 
7. Drugs such as  chemotherapeutic agents, steroids
23
, granulocyte colony stimulating 
factor. 
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Different studies have reported variable incidence of hypersegmented neutrophils in 
megaloblastic anaemia. The incidence of hypersegmented neutrophils in a study in Chinese 
population by Chan et al shows the incidence to be about 68%
24
. 
 
 
Figure1: Peripheral smear picture in a patient with megaloblastic anaemia showing a 
hypersegmented neutrophil and macrocytosis 
 
 
Figure 2 Peripheral smear picture with hypersegmented neutrophils 
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Figure 3: Bone marrow picture in a patient with megaloblastic anaemia 
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DIAGNOSIS OF MEGALOBLASTIC ANAEMIA 
Determining the serum level of vitamin B12 is the preliminary step in evaluation of 
megaloblastic anaemia. Quantaphase Radio II assay which is an older and an non-automated 
protein binding method was subjected to various studies, has sensitivity of 95-97%.
25
 
Nowadays it can be done in a fully automated method. This method is expected to have 
sensitivity atleast as that of non-automated method. Excluding wholly vitamin B 12 
deficiency inspite of normal serum levels of B12 not entertained. The following are the 
conditions in which there would be more than expected level or normal vitamin B12 levels 
even in the face of deficiency: 
1. Renal failure  
2. Liver disease 
3. Chronic myeloid leukaemia (CML) and also other myeloproliferative disorders  
4. Nitrous oxide inhalation 
5. Congenital transcobalamin II deficiency. 
6. Metabolism errors of intracellular B12  
7. Parenteral therapy with Vitamin B12 supplements  
 
In elderly population Methyl malonic acid along with total plasma homocysteine, considered 
as B12 related metabolites are found to be elevated in decent proportion of patients with low 
normal or high normal B12 levels in the serum. One of the study has stated  that  35% of their 
study population with low-normal B12 levels, i.e. the levels between  140–258 ng/l, and 24% 
of study population with high normal levels, i.e. the level  >258 ng/l, had increased levels of 
serum methyl malonic acid and plasma total homocysteine. But the high levels of MMA was 
seen only in 12 and 11% of the population, respectively
26
. In view of this few researchers 
have advised complete evaluation of status of serum B12 in the patients who has B12 levels 
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are higher than the lower 95% upper limit for  vitamin B12. If it done so i.e  practicing  this 
methodology might cause unnecessary evaluation and testing of many individuals  among 
whom there might not be deficiency of B12 vitamin  and certain fraction of persons in whom 
there might be subclinical deficiency
27
. Some of the conditions are often found to be 
associated with reduced  vitamin B12 assay levels in spite  stores of the vitamin is well with 
in normal 
1. Pregnancy 
2. HIV infection 
3. Folate deficiency 
 4. Patients on anticonvulsant drugs 
 5. Myeloma 
6. Transcobalamin I deficiency 
7. Unexplained 
 
Mild and occasionally severe TC I deficiency
28 
 may cause low serum B12 levels in about 
fifteen percent of general population of patients and  low levels of B12 without malabsorption 
or any abnormality seen in the B12 metabolite. Determination of the presence of 
Transcobalamin I deficiency is made by Radio immune assay. Methylmalonic acid and 
plasma total homocystreine levels are increased in the face of vitamin B12 deficiency. The 
problem with Methylmalonic acid assay is that it is of high cost, accessibility and a duration 
taken to report is significantly longer. Provided that renal function has been ruled out, 
estimation of serum MMA levels would be of highly indicative of low B12 levels. 2% of 
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cases with folate deficiency and 98% with vitamin B12 deficiency have elevated 
Methylmalonic acid levels
25
. Homocysteine assays are less expensive but the availability is 
wider when compared to serum Methylmalonic acid assays. The sensitivity of homocysteine 
assay is 96% 37 and 91% in cases of B12 and folate deficiency respectively. Estimating 
serum homocystein levels might be helpful in the following patient population i.e. Kidney 
injury with reduced GFR, over consumption of alcohol, low level vitamin B6, 
hypothyroidism, patients taking drugs like Isoniazid and defects in homocysteine metabolism. 
Supplementation of vitamin B12 to the deficient patient may normalize their  methylmalonic 
acid and homocysteine levels  but it would not occur when they are supplemented with 
folate
29
. 
 
Holotranscobalamin II (holo-TC II) 
Transcobalmin II  is a protein that transports B12  and supplies it to the cells for metabolism. 
This happens in about 6–20% of the total serum B12. Transcobalamin I (haptocorrin) binds 
the rest of all the B12 whose function is not evaluated in full. Above finding has enabled us to 
know that estimating the level of TC II-bound B12 (holo-TC II or holo-TC) would provide us 
the exact amount of vitamin B12 available for cells for metabolism. In earlier days were older 
methods were followed for estimating  holo-TC II it was noted that the levels were interfered 
with other conditions than that of B12 status  affecting in specificity. It has been found by 
various researchers the new radioimmunoassays  is more sensitive than estimating B12 levels  
in establishing the diagnosis in individuals with more than normal levels of MMA and 
tHCYS levels
30
. Before using holo-TC II further research work is needed  as there are  
conflicting data on specificity of using and further studies are required before the value of 
holo-TC II in determining B12 status is established.
31,32,33
. Eighty nine percent was specificity 
of this assay as identified by one of the study. Chen et al 
34
  after his research work recently  
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stated that  deficiency of B12 was much more important than impaired B12 absorption in 
measuring the level of  holo-TC II. Significant amount of overlap was noticed within  serum 
holo-TC II levels among the  patients  who were treated for  pernicious anaemia and control 
patients who does have the disease. This was in contradiction to older suggestions, finally 
concluding that estimating and identifying holo-TC II levels may not  be used as a surrogate 
for the Schilling test.  
 
 
DEOXYURIDINE SUPPRESSION TEST (DUST) 
The efficiency of the hematopoetic cells involved in the metabolism of converting 
deoxyuridylate to thymidylate by the process of methylation is identified by the above test. It 
have been found that it is been abnormal in both B12 and folate deficiency 
35,36,37,38
.Worldwide, it is found that this test is being performed only in few of the 
laboratories. The DUST is more sensitive in detecting B12 deficiency than MMA or tHCYS 
levels
38
. It has the main draw back since it is being performed by using bone marrow cells 
which might involve an invasive procedure. 
 
BIOCHEMICAL TESTS FOR ASSESSING FOLATE STATUS IN SERUM AND RED 
CELL  
In human body the storage status of folate is evaluated by measuring the level of folate in the 
serum or else in the red blood cells. Majority of the proportion of folate in the serum would 
be in the form of 5-methyltetrahydrofolate monoglutamate. Likewise in the red blood cells 
folate would be in the form of polyglutamates. Since the life time of red blood cells are about 
three months measurement of red cell folate would give us an estimate of the vitamin over a 
period of three months. In general since the folate level in the serum mostly reflects the 
current or short term intake of the vitamin its measurement is mostly useful identifying recent 
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folate deficiency
39
. Various other research works had showed statistical correlation among the 
values of folate in the serum and red blood cell which was done by using microbiological and 
fully-automated methods
40,41
.  Based on the above reports few of them stated that folate level 
in both serum and red blood cell might offer same amount of clinical information. In the 
studies it was found that there was a weak correlation. By analyzing the statistics in the 
studies conducted by  Jaffe & Schilling
41
 and  Phekoo et al
40
 it is observed  that only 30%  
and 24% respectively in the above studies , the variation of the serum folate can be accounted 
by variations of red cell folate. 
 
In estimating the folate levels the precision of folate assays, predominantly of fully-
automated red cell folate assays is debatable. It have been stated that the results obtained 
depend on what method was used for  estimating the levels i.e by microbiological method or 
radioassay or  fully-automated or GC-MS
42,43
. This type of variation in the results when 
different methods are used is because the haemolysate preparation differs and there is 
difference in deconjugation of folate poly glutamates to mono glutamates. Since the red cell 
derived mono glutamates contains combination of various species it would be tough to make 
assay design. 
 
It has been found that nearly sixty percent of the patients with low B12 have their red cell 
folate to be low. This makes the red cell folate assay to be low specific in diagnosing folate 
deficiency. But in those patients twenty percent had increased serum folate levels and ten 
percent had low serum folate levels. When patient has normal B12 and low folate level, in 
clinical practice then only the patient is said to have folate deficiency. When both folate and 
B12 are found to be low firstly the possibility of B12 deficiency is considered instead of 
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folate taking into the consideration of the clinical scenario. It would be advisable to do a 
MMA assay or Schilling test can be done.  
We cannot expect metabolic abnormality of folate or B12 in all patients presenting with 
reduced red cell folate levels. Only 8 out of 45 patients with macrocytic anemia was found to 
have low red cell folate in one of the study. Radio assay was used in this study. Those patients 
had  normal DUST results
44
. 
 
Plasma total homocysteine (tHCYS) and serum/plasma methylmalonic acid (MMA) 
As we are aware by previous discussion tHCYS is elevated in both folate and B12 deficiency. 
Hyper homocysteinemia is recovered  when such patients are  supplemented with folate than 
that of B12
29
. The levels of MMA is not affected by low folate levels.  
 
 
TREATMENT 
 
Cobalamine deficiency 
Apart from specific therapy related to the underlying disorder, the mainstay of treatment for 
cobalamine deficiency is replacement therapy. Parental treatment begins with 1000 micro g 
cobalamine daily for 1 week followed by weekly for eight weeks and then  monthly once  for 
the rest of patient‟s life. 
Folate deficiency 
As for cobalamine deficiency, folate deficiency is treated by replacement therapy. The usual 
dose of folate is 1 mg/d by mouth, but higher doses (upto 5 mg/d) may be required for folate 
deficiency due to malabsorption. 
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OTHER CAUSES OF MACROCYTOSIS 
HYPOTHYROIDISM 
Prevalence of hypothyroidism have been reported to be 2-5% worldwide even though the 
incidence varies among the different geographic area. Conversely, subclinical hypo 
thyroidism has the prevalence roughly between 4 to 8.5%. It is also noted that prevalence of 
sub-clinical hypo-thyroidism would rise upto twenty percent in women in the age group of 
sixty or more older
45
. 
 
Metabolic deceleration occurs in the state of hypothyroidism. All the organs in the human 
body is affected .The manifestation of thyroid deficiency, symptoms and findings would be 
different characteristics which depends on the age of onset of the disease and also the 
deficiency or inefficiency of the thyroid hormones.  
 
Among many manifestations of this disease state anemia would be most common and 
important presentation since it affects the hemotopoietic system. Mediocre anemia is 
commonly seen in hypothyroidism. About 20 to 60% patients are said to have anemia in 
hypothyroid state. 
 
Various types of anemia like normochromic normocytic, hypochromic microcytic, and 
macrocytic would be a presenting feature in hypothyroid. It is also stated that the level of 
haemoglobin drop depends upon the severity of thyroid deficiency. Findings of hypocellular 
features in   the bone marrow indicates that thyroid hormone also plays an important role in 
hamatopoiesis. 
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In a normal clinical setting normochromic normocytic anemia is most commonly seen. The 
most common cause is the bone marrow suppression due to low level of thyroid hormone and 
also insufficiency of erythropoietin secretion or production because of decreased oxygen 
demand. Life cycle of the red blood cells is found to be normal in hypothyroid state and also 
there would be hypoproliferative erythropoiesis. Thyroid hormones are necessary in 
production and it also increase 2-3 DPG (diphosphoglycerate) levels supporting in the  
delivery and diffusion of oxygen inside  the cells 
46,47,48
. 
 
Patient would present with features of various other autoimmune disorders if the patient has 
autoimmune thyroid disorders. Pernicious anemia an auto immune disorder might 
complement thyroid deficient state as a component of polyglandular auto immune syndrome. 
The theory proposed as a cause for macrocytic anemia in thyroid deficient state is that 
intrinsic factor deficiency and absence of hydrochloric acid in gastric secretion leads to poor 
or nil absorption of B12 vitamin. Another study states  55% of the hypothyroid patients  have  
associated  Macrocytosis
49
. Iron deficiency anemia is linked with menorrhagia happening as a 
result of various hormonal disproportions and also malabsorption which is seen in 
hypothyroidism
50
. In hypothyroidism
51
 reduced  absorption of folate is also noted to be  the 
triggering factor for anemia with macrocytosis. 
 
MEGALOBLASTS IN ALCOHOLIC 
In chronic alcohol consuming patients occurrence of megaloblasts in their marrow is seen. 
The above feature is noted in approximately one third of the patients consuming alcohol who 
has presented with features of anemia
52
. It is found that persons who consume alcohol 
chronically will have low folate in their red blood cells. The important reason for this 
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deficient state is consumption of food very much low in folate levels. Because of their poor 
dietary pattern this is most commonly seen in persons consuming alcohol. Added to this poor 
eating pattern consumption of alcohol by itself leads to foalte deficient state affecting the 
absorptive ability of intestines of folate present in the diet.  
 
The aberrations in synthesis of red blood cells evidenced because of alcohol consumption is 
not exclusively found in marrow but also seen in peripheral blood by the existence of 
abnormal red blood cells.  
 
Obviously large sized red blood cells seen in the peripheral blood – a feature named as 
macrocytosis along with morphologically  unusual red blood cells  that are undergoing  early 
or hastened demolition a phenomenon called as  haemolysis  occurs due to their abnormality 
in the structure. Due to the above fact patients with chronic alcohol consumption most often 
have the diagnosis of macrocytic anemia. 
 
It is been noted that comparing the mean corpuscular volume of the red blood cells using 
automated machine for counting the cells between the patients who consumes alcohol and 
who does not, the patients who consumes alcohol had their MCV to be higher.  Nonetheless, 
when the MCV is high macrocytosis should not be made as a diagnosis routinely. Occurrence 
of bigger red blood cells in the peripheral smear not only meant because of alcohol but there 
are many diverse diseases. It is also very essential to examine the red cells using a 
microscope in order to establish a diagnosis of macrocytosis, and also to recognise the 
various abnormal structures distinctive for various other specific diseases. Hence the bloated 
RBC‟s in persons having macrocytosis usually are homogenously round, where in oval 
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shaped red blood cell are predominantly seen in anemia with megaloblastosis. Apart from 
that, alcoholism leading to macrocytes in the blood could be diagnosed only after exploring 
all the prospective reasons for enlarged red blood cells along with the history of consuming 
alcohol
53
. 
 
Production of red blood cell is found to be reduced by alcohol and also due to cirrhosis 
caused by alcohol. Hypersplenism, a situation characterized with increased size of the spleen 
and reduced number of red blood cells or WBC or platelets or all can cause untimely 
demolition of red blood cells. Principle site of loss of blood is found to be through intestines 
and is amplified in those persons with lower platelet counts. Postulated causes of anemia in 
alcoholism are
54
 
 Hypersplenism 
 Losing Blood  
 Liver disease 
 Low folate levels 
 Lower  red blood cell synthesis  
 
People who drink too much amount of alcohol can have enlarged red blood cells i.e 
macrocytosis inspite of other contributing reasons for increased red cell size found in 
consuming alcohol chronically like cirrhosis or other liver disorders associated with alcohol 
consumption or deficient folate. Its true that, excessive consumption of alcohol is the ailment 
frequently connected with enlarged red blood cells. Alcoholism was noted to be associated 
with enlarged red cells in up to  eighty  percentage of men and  forty six percentage of 
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women  in one study. The exact process leading to enlarged red cells is not known till now. 
Nevertheless it is noted there is direct interference of alcohol in growth of red blood cells, 
since the enlarged red cells vanish between two to four  months of self-restraint. 
 
Lysis of red cells might be a fundamental factor leading to anemia, and numerous types of 
haemolysis may be triggered by consumption of huge amount of alcohol for longer period. 
Among numerous type of red cell destruction two of them are associated characteristically 
with the existence of abnormally shaped red cells called as stomatocytes and spur cells
55
, 
although lysis of red cells occurs due to low phosphate levels in the serum because of chronic 
alcohol consumption.  
 
Diagnosis of red cell destruction in patients with alcoholism is demanding, since these 
persons commonly show other associated illnesses, like as alcohol withdrawal, low serum 
folate levels, blood loss and large sized spleen. When cells are seen under a microscope 
stomatocytes are seen as mouth or stoma shaped, this is because of fault in the red cell 
membrane. Destruction of the this abnormal stomatocytes occurs in the spleen as they get 
caught in the smaller capillaries within the spleen following which cells are destroyed leading 
to an abbreviated life span for red cells. Even in normal persons less than five percentage is 
occupied by stomatocytes in the total red cell count. However the percentages are found to be 
considerably greater in alcohol consuming persons. Indeed, greater than twenty five 
percentage of persons consuming alcoholic chronically will  display an amplified percentage 
of stoma shaped red cells  called as  stomatocytosis
56
. 
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The precise process that leads to the production of stomatocytes in alcoholics is quite 
uncertain. Liver disorders associated with alcohol consumption could be one of the causes in 
the production of stomatocyte. 
SPUR-CELL HEMOLYSIS
55
 
Spur cells are distorted RBC‟s that are characterized by spike like protrusions of their cell 
membrane. These spurs are produced by the integration of superfluous amounts of cholesterol 
into the cell membrane, ensuring an increase of the cell‟s surface area without a concomitant 
increase in cell volume. Modestly elevated membrane cholesterol levels result in a flattened 
RBC shape, however larger increments of cholesterol cause the membrane to be thrown up 
into spikes. Spur cells may be prematurely eliminated in the spleen. Spur-cell hemolysis 
occurs in about 3 percent of alcoholics with advanced liver disease, causing anemia that 
progresses relentlessly and is eventually fatal. Clinicians have tried unsuccessfully to treat the 
disorder using various agents with cholesterol-lowering properties. Consequently, surgical 
removal of the spleen is the only treatment capable of slowing the hemolytic process. Most 
alcoholic patients with spur-cell hemolysis, nevertheless, are not tolerable candidates for 
major abdominal surgery, since their coexisting advanced liver disease increases their risk of 
bleeding. Moreover, the procedure may precipitate liver failure 
 
HYPOPHOSPHATEMIA 
Even though hypophosphatemia- induced hemolysis is uncommon, its most common cause is 
alcoholism, particularly in the course of the withdrawal phase. Phosphate is an indispensable 
element of adenosine triphosphate (ATP), a compound that affords energy for numerous 
cellular processes. Alcohol effects phosphate to be expelled with the urine. Intense 
hypophosphatemia may cause the phosphate and ATP levels in the RBCs to drop markedly. 
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This reduction of the store of ATP in the RBC‟s leads to amplified rigidity of the RBC 
membranes, ultimately damaging the cells. These damaged cells are in advance, destroyed in 
the spleen, and the patient may progress acute hemolytic anemia. 
 
PREGNANCY INDUCED MACROCYTOSIS  
The association of anemia and pregnancy is well familiar. In this country the anemia is 
frequently due to iron deficiencies and is hypochromic. In the tropics a macrocytic, 
hyperchromic anemia of pregnancy has fascinated consideration and has been the theme of 
many current investigations. Its complement in the temperate climates, the macrocytic  or so-
called pernicious anemia of pregnancy, has been considered a comparatively infrequent 
dyscrasia. The macrocytic anemia of pregnancy was first recognized over a century ago when 
Channing described ten mortal cases. In 1919 Osler distinguished the so-called pernicious 
anemia of pregnancy from classic Addisonian anemia by indicating out that when recovery 
from the former disease took place it was everlasting and the woman might escape it in 
succeeding pregnancies. 
 
Anemia associated with pregnancy could be a significant problem faced in public‟s health 
causing substantial influence in increasing the mortality and morbidity among the mothers 
and child perinataly. In India with in a period between 1992 and 1994
57
 world health 
organisation described the link of anemia in about sixty four percentage death among the 
pregnant women. Pregnancy alone may by it self lead to anemia by producing a situation   of 
hydremic plethora. It can be noted there might be an unbalanced rise in volume of the plasma  
as equated to  the masses of the red blood cells in pregnant patients  causing an  visible drop 
of count in the red blood cells, hemoglobin and hematocrit value. The peripheral smear would 
show normo chromic and normo cytic anemia. This is pretended physiological anemia of 
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pregnancy. Other nutritional deficiencies like iron, folate, B12 vitamin and protein can 
aggravate and complicate this state of physiological condition. It is also noted anemia would 
also result from other associated factors hemolysis and bleeding disorders, also due to losing 
blood acutely or chronically. Predictably, anemia due to low serum iron is being equated with 
anemia of pregnant women and various literatures has recognised it. Recent studies
58,59
 also 
found the same. 
 
Anemia with macrocytosis contributes significantly to the anemia of different causes even 
though the occurrence and cause may not be consistent among given population. With 
growing occurrence of anemia in the community, it can be anticipated that the prevalence of 
macrocytic anemia among pregnant women would also be showing a growing trend. 
Amazingly, only low number of studies are existing in order to establish this fact, details on 
profile of the participant people and outcome of the pregnancy in those patients. 
 
Studies conducted with in the general Indian public have  shown upto sixty percent  low B12 
vitamin prevalance and 2.4% of anemia patients have peripheral smear study of 
macrocytosis
60,11
, but surprisingly no researches have  reported  it at the time of  pregnancy. 
This might have happened because higher occurrence of iron deficiency anemia has 
outshined it. Only study that could be seen in the literatures is a Venezuelavian study that 
deals with the issue of anemia with macrocytosis among pregnant women. This study 
disclosed that upto 36.32% study population had low folate levels and upto 61.34% had low 
B12 vitamin levels in pregnancy. In disparity, a study conducted in Americans the it was only 
between 3 to 4 percentage among the women with anemia with macrocytosis. Dietary pattern 
of the Americans was found to be the important reason for this lower occurrence of folate and 
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B12 vitamin deficiency which are the foremost cause for anemia with macrocytosis
61
. Their 
food has the richest sources of those vitamins. 
 
DRUG 
Our knowledge on  various pathogenesis of blood disorders caused by ingestion of drugs has 
improved as years have been progressing, principally that involves RBCs. Anemia due to 
lysis of red blood cells is the utmost common finding. Lysis of red cells occurs because drug 
might damage the red cell which activate an immunopathognetic mechanism or by the 
interruption of enzymes involved in the metabolic process of the red blood cell. The immune 
source of drug causing lysis of red cells is considered significant as  on the presentation of the 
patient and manifestation of lab results, various other diagnostic options and it is the foremost 
pathogenesis  involving in lysis. Drug that causes lysis of red cells by inducing oxidative 
stress occurs both in normal persons and also in persons deficient of certain enzymes. 
Particularly glucose-6-phosphate dehydrogenase deficient persons have red cell lysis more 
commonly. Few of the drugs can induce red cell abnormality by affecting young red cells in 
the marrow. By an ill known process these drugs affects and stops the development of red 
cells. Other drugs might produce a particular effect on the metabolism of red cell pre cursors. 
Those are the drugs that comprises of a process that hamper the production of DNA and  
producing megaloblastosis during erythroid synthesis and those that interrupt function of the  
mitochondrium and the production of heme leading to sideroblastic erythropoiesis. The 
following are the drugs leading to sideroblastic anemia: anti tuberculous drugs, heavy metals 
like lead, ethyl-alcohol and chloramphenicol.  
Many drugs used in therapeutics are implicated to cause adverse drug events by disturbing 
the haematological  synthesis  in  animals, found in various studies.  Adverse drug events is 
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been characterized as Type-A or Type-B reaction. Type-A adverse drug reactions have the 
characteristics of are dose dependency, which might be increased in certain group of the 
people. Type-B adverse drug reaction are characterised by idiosyncracy that they are not 
related to the drugs pharmacological effects. Drug adverse events caused by idiosyncrasy are 
more perplexing to  explain  because  they are not able predict their effect and the process 
involved are many more. It is found that an exclusive genetic and or acquired proneness of 
the particular person is commonly intricated. Predisposition of the person genetically for a 
drug adverse event has mutations that change metabolic process involving the drug or 
persuade immune reactions against the particular drug or else on its metabolic products. 
Because of  a change in the homeostasis  that occurs because of  the altered or abnormal 
function of the liver or the kidneys  metabolic process of the drugs or their end product 
excretion are changed there might be acquired predisposition  to adverse drug reaction. 
Prognosis of the adverse drug reaction depends on the organ and process by which the drug 
affects. Nevertheless finding a specific site of the effect or the process by which it occurs is 
tough since many number of sites and many process are involved. Locations of ill effect   
comprise the  various component of the blood and various component of the  bone marrow 
which includes  stem cells involved in hematopoiesis, their multiplying component cells and  
stromal tissue
62,63
 present within the marrow. Red blood cells are mainly predisposed to 
injuries caused by oxidation stress
64
. Various components of the marrow and peripheral cells 
also look as if they are exceptionally predisposed to immune induced lysis. This 
predisposition can be linked to the truth we know the binding of the antibody occurs on the 
blood cell surface in normal subjects as a way of finding and eliminating the older age cells. 
Consequently adverse events having immunological mediation might be considered as 
abnormally skewed immune process. Marrow precursor cells and cells undergoing 
proliferation are briskly dividing cells and hence they are predisposed to chemo therapeutic 
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drugs. Capillaries and sinusoids present in the marrow cavity are susceptible to the damage 
Damage to the vessels could be appreciated in marrow cavity by visualising swelling of the 
interstitium, bleeding, cell death, fibrosis of the marrow and various inflammatory cells in the 
core biopsy specimen. 
 
EVALUATING A PROBABLE ADES WITH EFFECT ON HEMATOLOGY 
The temporal relationship of a drug intake with a hematological effects do not by itself offers 
confirmation of an adverse event. Other prospective factors that might lead to such a 
hematological situations might be excluded by appraisal of the past and present history, 
features noted during physical examination and clinicopathological results.  
When neutrophil count is less than 1500 it is referred as neutropenia. Neutropenia is said to 
be an effect of adverse drug reaction when it has occurred with history of drug intake. 
Adverse drug event as a cause of neutropenia would not be drawn as conclusion when it has 
occurred within about four weeks of stopping the drug or has occurred more than four weeks 
after starting the drug if there was no leukocyte count done in the interval period. An 
elevation of the neutrophil count more than 1500 cells per micro-litres within four weeks 
after discontinuing drug intake is also in favour of adverse drug event.  
When the platelet count drops below one lakh it is called as thrombocytopenia. Manifestation 
of thrombocytopenia within four weeks of starting a drug or remission within three weeks  
after discontinuing drug  is indicative of ADE
65
.  
Depending upon the species and animal breeds the description of drug induced anemia 
differs. Moreover, the rapidity of developing anemia would depend on the process through 
which the drug causes anemia. Drugs that cause lysis of red cells intravascularly commonly 
leads to a speedy and increased severity in anemia with accompanying jaundice and 
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haemoglobin in the urine. Drug that causing lysis of red cells extravascularly is linked with a 
somewhat less speedy beginning of anemia and haemoglobin in urine and jaundice would be 
commonly lacking. Anemia would be of slow in progression when the drug leads to a 
hindrance to the erythropoietic process. 
 
TROPICAL SPRUE 
Tropical sprue is one of the more mysterious and rather poorly understood disease till now 
seen in tropical region. It is usually a clinical syndrome with an unknown etiology .Tropical 
sprue  has more characteristically an acquired chronic diarrheal illness, associated with small 
bowel mucosal abnormalities which may result in  malabsorption  leading to  nutritional 
deficiencies and loss of  weight
66
. Many of these symptoms are vague which are seen in large 
number of other diseases. Diagnosis of tropical sprue is quite challenging as the endoscopic 
findings and histology of the specimen obtained from endoscopy is mostly non specific
67
. 
“Idiopathic Mailabsorption of the tropics” is the term used to describe the patients with 
chronic diarrhea by Dr.William Hillary in 1795
68
. It was broadly defined  as malabsorption of 
two or more substances in people in the tropics when other causes have been excluded by  
Baker, in 1974
66,67
.   
 
Ghoshal, who has extensively studied on Tropical sprue over the past decade has often 
quoted Klepstein‟s definition, which focused on very specific criteria. Individuals must have 
the following features to meet the criteria: chronic small bowel diarrhea with malabsorption 
of two unrelated substances (i.e. carbohydrates and fatty acids), abnormal small intestinal 
histology, excluding the  other known cause of malabsorption and consistent results to the 
treatment. Most important point in the definition is that the patient should be symptomatic
69
. 
It was redefined by Klepstein, which excludes the asymptomatic, healthy individuals who are 
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living in tropical region and also demonstrate villous abnormalities
66
. Patient presenting with 
these features are classified as having tropical enteropathy instead of TS. Patients with 
tropical enteropathy have features of subclinical malabsorption, they neither have diarrhea 
nor  show clinical evidence of malnutrition
70
,
71
,
72
. 
 
It is known that the tropical sprue is prevalent in our country and even in Indonesia, Burma, 
Borneo, Singapore, Malaysia and Vietnam. But in China, Africa and Middle East it is less 
well known
73
. Tropical sprue has rarely been seen in the literature in United State. There are 
many factors to support that tropical sprue is due to infection and they are as follows
74,75
 
1. Acute diarrhoeal disease, characteristically an infectious diarrhea often preceeds the 
disease. 
2. Following the epidemics of diarrhea few patients were found to develop tropical sprue 
in epidemic. 
3. Toxin producing coliform bacteria is found to be over grown. (Enterobacter, 
Escherischia coli and Klebseilla) 
4. Usage of broad spectrum antibiotis cures the disease. 
Bacterial overgrowth  causes fermentation and release of toxigenic substances as a byproduct 
might cause small intestinal mucosal injury resulting in malabsorption. 
1. Alcohol produced as the product of fermentation inhibit folate absorption leading to 
folate deficiency. 
2. As the disease process involves the terminal ileum leads to malabsorption of Vitamin 
B12 and it becomes deficient.  
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3. Deficiency of disaccharide enzymes such as maltase, sucrose and lactase lead to 
Carbohydrate malabsorption 
4. Malabsorption leads to Vitamin D deficiency which often causes hypophosphatemia 
and hypocalcemia. 
5. Magnesium deficiency may occur. 
6. Alteration in the villous architecture may cause fat malabsorption leading to 
steatorrhoea 
 
Tropical sprue most commonly presents with 
1. Diarrhoea 
2. Easy fatiguability due to megaloblastic anaemia because folate and or vitamin B12 
malabsorption. 
 
The other clinical features may include chelitis, glossitis and pedal edema. Neurological 
manifestations of vitamin B12 deficiency in tropical sprue are rare. Procedure like upper GI 
endoscopy with duodenal biopsy is often used for diagnosis. Large intestine may also be 
involved in Tropical sprue. Scalloping and flattening of duodenal folds are the endoscopic 
findings that have been originally thought to occur in Celiac disease also occurs in Tropical 
Sprue
76, 77
. Eventhough spontaneous recovery from mild tropical sprue have been reported, 
most authorities recommend treatment with tetracycline (250 mg PO four times daily) plus 
folic acid (5 mg/day) for three to six months. Relapses or reinfection occur in up to 20 
percent of patients living in the tropics when treated with this above regimen. 
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Most of the signs and symptoms of tropical sprue reverses with supplementation  of oral folic 
acid
78
. Most of the patients treated with effective dose of folic acid (1 to 5 mg/day) within 
several weeks, show increased sense of well being, weight gain and improvement in anemia. 
This type of dramatic symptomatic response occurs more frequently to oral folate therapy in 
tropical sprue and so rarely (if ever) in other forms of small bowel disease with megaloblastic 
anemia that it is considered to be diagnostic of the illness. Morphologic abnormalities noted 
in the small intestines which suggest villous atropy could be the aetiology in tropical sprue is 
also corrected by the replacement of folic acid. This also suggests that villous atrophy is due 
to folate deficiency. 
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Table 1: Small bowel mucosal histology in various malabsorptive disorders 
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Table 2: Symptoms of malabsorption 
 
 
 
 
 
LACTATE DEHYDROGENASE
79,80
 
Lactate de-hydrogenase iso-enzymes in human beings are chiefly utilised by cellular 
components in particular tissues. Human LDH Iso-enzymes, which is even called as lactic de 
hydrogenase, are accountable for transforming lactic acid into pyruvic acid in the muscular 
tissue which is a vital process in generating energy in the muscle cells. If there happens a  
damage to the cells, cells comprising particular iso enzyme of LDH is freed in the circulation. 
Evaluating the ratio of particular iso-enzymes would lead us to recognise definite pattern in 
order to help in diagnosing the diseases such as myocardial infarction, injuries to the lung, 
hepatic diseases, disorders of muscular tissue, various late stage carcinomas and auto-
immune diseases. Various disease processes linked with elevated Human lactate de-
hydrogenase (LDH) isoenzymes are as follows: 
Glossitis
Night blindness
Pain in limbs, bones, pathologic fractures
Peripheral neuropathy
Symptoms of Malabsorption
Symptom
Anemia (hypochromic, microcytic)
Anemia (macrocytic)
Bleeding, bruising, petechiae
Carpopedal spasm
Edema
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LDH 1 isoenzymes: tumor associated with germ cells. 
LDH 1 > LDH 2 isoenzymes: kidney injury and Cardiac muscle necrosis, megaloblastic 
anemia, lysis of red cells. 
LDH 3 isoenzyme: platelet damage, reactive Lymph adenopathy, lymphoma,         
lymphocytosis, pulmonary infarction, pulmonary infection i.e. pneumonitis, late stage 
advanced carcinomas, acute pancreatitis. 
 LDH 4 isoenzyme – different type solid tumours. 
 LDH 5 isoenzyme: primary hepatic/liver disorder, anoxic injury of hepatocytes, muscular 
damage or degeneration. 
All the isoenzymes: Kidney disorders, end stage carcinomas, collagen vascular disease, 
severe sepsis, disseminated intravascular coagulation. 
When illness or damage occurs in the tissues encompassing LDH, the cellular structure would 
discharge LDH within the circulation, from where it can be recognized in abnormally high 
levels. For an instance, if an individual has a myocardial infarction the levels of the LDH 
starts to increase in about twelve hours after the infarction and generally the levels might 
return to base line in about five to ten days. The LDH is also  seems to be raised in  hepatic 
disease, in particular type of anaemias, and in condition associated with  tissue damage in 
excess as found in bony injury, traumatic injury, muscle destruction and severe shock. 
Certain types of tumours lead to an elevated levels of LDH. Moreover few patients have 
chronic elevation of LDH with no specific cause and without any effect. 
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PREPARATION 
Estimation of LDH is done in blood samples. It does not require the person to be in the 
fasting state when the test is being done. 
 
NORMAL RANGE 
There might be variation in the values of LDH as coated as references, between lab to lab. In 
children the normal range of LDH might be high. But in adult population many of the labs 
have the value ranging till 200 units/L, although typically the value is in between 45 to 90 
Units/Litre. 
 
ABNORMAL  RANGE 
Total lactate dehydrogenase comprises of mixture of 5 types of iso enzymes of LDH and 
even though many diseases lead to elevation of LDH, diagnosing the specific disease process, 
each component is useful. LDH is often helpful for diagnosis. It is known that total lactate 
dehydrogenase might be well within the usual range but a specific iso enzyme would be 
elevated indicating injury to a particular tissues or organs. This can be explained by the 
following fact that in normal situation the component of LDH 2 within the total is higher 
when compared with that of LDH 1 in a given sample. But following acute myocardial injury 
the fraction of LDH 1 would rise beyond the fraction of LDH 2 which is termed to be 
"flipped LDH." It is also known that determining the total LDH might be helpful in 
diagnosing a particular disease. This can be explained by the following, when there is a 
disease infectious mononucleosis, it would lead to higher increase of   LDH than that of a 
hepatic enzyme aspartate transaminase. But in converse infection of the liver by hepatotropic 
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viruses may lead to a great elevation of the hepatic enzymes like AST and ALT than that of 
lactate dehydrogenase. 
ENZYME 
It is a protein regulating the speed of a reactions involving the chemicals inside the tissues 
and it also increase the rate of the reaction. 
ISOENZYME 
These are the enzyme groups that help in same chemical reaction but they tend to have 
different property physically.  
Since there might be variations in the LDH values because of varying conditions while 
collecting sample and also transporting it should be taken into account while interpreting the 
results. Even though lysis of the blood cells is usually identified easily and the information is 
notified to the labs, other processes which include lengthy refrigeration of un-centrifuged 
sample or centrifuge, over heating may lead to an increased level artificially. When the test is 
repeated this could be clarified. In the situation where the other lab features and clinical 
features are not present, estimating LDH iso enzyme levels would provide the best direction 
towards making a diagnosis. Alternative likelihood is occult tumours. But in this situation  
with high elevated  LDH  there might be raise in blood uric acid  levels and if there is hepatic 
involvement alkaline phosphatase and gamma glutamyl transferase would be raised. 
Requesting many of the blood markers for diagnosing a tumour in general is of low value. 
Instead of that possibly the more helpful methodology is additional thoroughly examining the 
patients clinically and probably few other investigations to rule out multiple myeloma. 
Mainly in the elder population of patients LDH is found to be commonly elevated because of 
the cardiac valvular disease leading to lysis of the red cells. Above process is associated with 
                                                     
36 
 
low levels of haptoglobulin because of binding with the free haemoglobin and commonly 
associated with increase in reticulocyte count and raise in indirect fraction of serum bilirubin. 
 Diagnosing the patient is made mostly simplified with good clinical history. Matured cells 
would display LDH 1 and LDH 2 iso enzymes. Above feature is seen most often in all 
process comprising more and more turnover of the cell in conditions like abnormal 
hemoglobulin, erythropoeitic inefficiency and absorption of huge blood clot. 
Inflammation of the myocytes and lower level of degeneration of skeletal muscles can lead to 
elevated levels of LDH. Even though creatinine kinase is more often increased this is 
sometimes not the scenario. Easy fatigability and loss of power are the clinical features that 
might had gone unnoticed during eliciting history. Lactate dehydrogenase iso enzyme would 
show an elevated LDH 5 fraction with lower level of elevated LDH 4 iso enzyme, a type that 
is fundamentally cannot be distinguished due to a hepatic origin, even though a normal ALT 
level contends intensely not in favour of the hepatic origin. In order to clarify it more clearly 
tests to detect antibodies and tests for the functions of the thyroid gland is helpful. LDH 
levels are found to be a good marker for sickle cell anemia activity in pediatric population. In 
younger people with haemoglobin SS and haemoglobin C the values of serum lactate de 
hydrogenase (LDH) is measured and its association with vascular changes in the brain 
identified by transcranial Doppler scanning (TCD) is been studied. In a study all child 
population having Hemoglobin SS (n = 97) and Hemoglobin SC (n = 18) were undergone a 
transcranial Doppler study scan. Their lactate dehydrogenase values were compared with 
transcranial Doppler findings. It was found that there was appreciable and positive 
correlation. Population with haemoglobin SS was found to have higher lactate dehydrogenase 
levels when compared with those of haemoglobin SC disease. It showed a significant 
statistical difference. It was also noted that level of lactate dehydrogenase in child population 
with haemoglobin SS, was related considerably with level of red cells, reticulocyte, AST and 
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creatinine. Serum LDH values along with glycolysis considerably associated with tumor 
vascular endothelial growth factor A. 
 
RED CELL DISTRIBUTION WIDTH 
The greatest vital features of doing a complete blood count is that of identifying level of 
RBC, total leucocyte number, the percentage of different leucocytes and number of platelets. 
Nevertheless recent lab machineries used for complete blood count offer more features by 
enabling to provide more derived values
81
. Derived parameters include features of RBC and 
platelets. They are - Mean Corpuscular Volume, Mean Corpuscular Hemoglobin, Mean 
corpuscular haemoglobin concentration, Red cell distribution width, Mean platelet volume 
and Platelet distribution width. Above indices are very well helpful in making a diagnosis. 
But such indices are not used properly used since many doctors are not familiarised with that. 
Few of the indices are additionally included in the complete blood count results and its 
implication may be unknown for majority. The Red cell distribution width is one such 
indices.  
 
 
EVALUATION  OF THE RDW
82
 
Inspecting the peripheral blood picture microscopically would show many red cells with 
different sizes that is stated as anisocytosis.  This is, nevertheless, done little subjectively and 
could be performed most approximately. Latest automated electronic haematological 
machines would judge the volume of red blood cells without difficulty and more precisely, 
permitting an accurate value of the red cell index that gives variation in red cell volume. 
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The measurement is known as the „Red Cell Volume Distribution Width‟ or RDW in 
abbreviation. This is calculated and derived as the Coefficient of Variation (CV) and is 
calculated by the following. Mathematically the RDW is derived using the following 
formula: 
RDW = (Standard deviation of red cell width ÷ mean cell width) × 100 
CV = Standard Deviation of red cell size ÷ MCV 
 
 
Table 3:  MCV Vs RDW 
 
Red cell distribution width is of mathematical measurement of anisocytosis. It might be of 
helpful in differentiating various factors leading to anaemia. But specifically in differentiating 
anemia of low serum iron which has high red cell distribution width and that of  
Thalassaemia which has normal red cell distribution width and also in differentiating anemia 
with Megaloblastosis which has a raised red cell distribution width and various other 
macrocytic anemia which might have usually normal RDW . It should be noticed that only 
elevated RDW are of more important and lesser values are not of significant. Sensitivity of 
MCV Low MCV Normal MCV High
Iron Deficiency Early Iron Deficiency B12/Folate deficiency
Hbg Disease Early B12/Folate defficency Immune Haemolytic anaemia
S/Beta Thalassaemia Sickle Cell Anaemia Cold Agglutinins
Hb1AC Sickle/C Disease Alcoholism
MAHA
Severe anaemia of chronic 
disorders
Thalassaemia trait Normal
RDW 
Normal
Anaemia of Chronic 
Disorders
Myelodysplasia
Hereditary Spherocytosis
Sickle Cell trait
RDW 
High
Aplastic Anaemia
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red cell distribution width is higher for finding abnormal feature in microcytosis than that of 
macrocytosis in a situation where the level of haemoglobin is on the lower range.  
 
 
Figure 4: Normal peripheral smear film with varied size of RBC  
 
 
Figure 5: Red cells in moderate iron deficiency showing varied in size (anisocytosis) and 
shape (poikilocytosis), and also microcytosis (low average cell size) and hypochromasia 
(increased central pallor). 
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The causative factors and or characters of Anisocytosis are as follows: 
Other  syndromes 
• Myelodysplastic syndrome 
Blood abnormality 
• Sideroblastic anaemia 
Biochemical abnormality 
• Folate deficiency 
Mendelian inherited disorders  
• Diamond-Blackfan anemia 
• Haemoglobin Bart's 
• Haemoglobin H disease 
Autosomal dominantly transmitted disorders 
• 4-hydroxyphenylpyruvate hydroxylase deficiency 
Autosomal recessively transmitted disorders 
• Beta-thalassaemia  
• Congenital dys-erythropoietic anaemia type II 
Nutritional disorders 
• Reduced Folate levels deficiency 
• Low Iron levels 
• Kwashiorkor (protein deficiency) 
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• Low Vitamin A  
• Low Vitamin B12 
Iatrogenic conditions 
• Blood transfusions and its consequences 
Normal range of RDW in human red blood cells is 11 – 15% 
 
RETICOUNT
83,84
 
Components of the blood cells all originate from a stem present in the bone marrow. During 
development on multiplication these stem cells segregate as different blood cell component 
lines i.e erythropoiesis, granulopoiesis and thrombopoiesis. The life span of the red cells in 
the circulation is about 120 days. One percentage among the total red cell mass is destroyed 
in a day and it is replaced by production of newer cells. About 2 million red cells are formed 
every second. The ortho-chromatic erythroblasts expel its nucleus from the cell and produce 
the reticulocytic cell that later joins the peripheral blood. In about a period of 4 days removal 
of the endoplasmic reticulum occurs leading to development of matured red cells. In general 
it is noted that the reticulocyte stay inside bone marrow for four more days and one more day 
in the peripheries. The term „reticulocyte‟ originates because of the web like structures 
present in the cells and that is evidenced by using supra vital stains like brilliant cresyl blue 
or methylene blue. This occurs because RNA fragments get precipitated. Reticulocyte was 
firstly described in 1865 by Erbs, who identified the reticulum present inside the cells with 
the help of picric acid. In 1881 with the help of supra vital staining, Ehrlisch identified a 
network called substantia reticulofilamentosa inside the cells. In 1891 Smith recognized 
reticulocytes to be precursors of red cells. In 1932 Heilmiyer classified the different stages 
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involved in the maturation of retic cells. In 1950 quantification of different stages in maturing 
with references was done by Seip. In 1960 reticulocytes were counted using fluorescence 
process with acridine orange. This was done by Kosinov & Maii. In 1983 automated retic 
measuring procedures with help of fluorescence technology and flow cyto metry was done by 
Tanki. 
 
RETICULOCYTES AND THEIR SIGNIFICANCE 
 
Table 4: Stage of Maturation – by Heilmiyer 
 
Different maturation stages more frequently are understood wrongly. Quite often stage I is 
expressed as an erythro blast and matured red cells as stage IV because their lower ribo 
nucleic acid component is undetected. The accurate analysis of stage IV is particularly 
imperative, because this is governed in blood peripherally. 
Because there was a  regular wrong interpretations of stage IV, Gelmer and Koipke gave a 
definition for  reticulocytes: „A reticulocyte is a red cell without nucleus, it should be having 
minimum 2 or greater particulates which stains blue  with  basophilic polyribosomal material 
within the cytoplasm while  stained using  newer methylene blue. These particle or the dot 
shall be at little away from the walls of the cell so that it is not been erroneously identified as 
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Heinzs body. Cells that have unambiguous, blue cytoplasmic granules, that might be 
visualised by not using fine focus is considered to be reticulocytes of maturation stage IV‟. 
In the year 1985 the National Committee for Clinical Laboratory Standards (NCCLS) in 
United states and the International Council for Standardization in Haematology (ICSH) 
described  cell having „single-dot‟  to be  as matured red blood cells but not retic cells  and 
incorporated and endorsed those to be as appraisal standard for microscopic (manual) 
counting and classification. Red cell regenerative process is reflected by the retic count. 
 
 In a well balanced condition more than ninety percent of the more matured stages of retic 
cells would be seen in the peripheries of the blood. If there is a stimulation for erythropoitic 
process, shift towards the early maturation stages occurs in the blood peripheries which is 
same that of shift towards left during granulopoietic process. 
 
 
Figure 6: Polychromasia and early red cell stages in more severly haemolytic process in e 
auto immune haemolysis  
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NEED FOR DOING RETIC COUNTS 
 As a preliminary test in diagnosing any anemia 
 To monitor the effect of supplementation of iron, folate and B12 vitamin. 
 To monitor the effect after erythropoietin injection 
 Following up of hematopoietic cell transplants 
 
SPECIMEN  
EDTA blood 
 
INVITRO STABILITY OF RETIC COUNTS
85
 
Finding reticulocytes with in EDTA blood can be relied until seventy two hours of taking the 
blood sample. When the sample is been stored in the  temperature of + 4°C or 20°C  does not 
produce  noteworthy change in the measuring results. 
 
PROCEDURE IN COUNTING MANUALLY 
Things essential for determining the reticulocyte count are supra vital stain, microscope slides 
and microscope. First step is to mix the specimen of whole blood along same amount of supra 
vital stains. Usually brilliant cresyl blue is used. Commercial preparation of the stain is there 
in the market in ready to use condition. The above mixture is allowed for incubation and a 
smear is prepared over a microscopic slides. Then smear is looked into by using a microscope 
through oil immersion magnifications. This gives thousand folds of magnifications. Counting 
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of thousand RBCs should be done. Because of thousand folds of magnifications it is 
equivalent to about 5 visual field. In one field there would be about two hundred RBCs. The 
retic count is reported in unit of per mil or in percentage. 
In various literatures it have been noted that there might be higher degree or errors in 
manually counted. They have cited that the percentage of error might be in the range of 20 
and 40. There is a standard recommendation to count thousands cells. Avoiding of More than 
5 percentage of error on statistics can be done when minimum of 4000 cells are counted.  
 
 
 
Table 5: Effects of numbers of counted RBCs over the error in statistics reticulocyte count. 
The numbers quoted denote a CV of five percentage. 
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Figure 7: Reticulocyte when stained with supra vital stains 
 
 
RETICULOCYTE COUNT USING AUTOMATED MACHINE 
Fluorescence stains that bind Ribonucleic acid are used in staining of the blood samples in 
order to count reticulocte. And the counting is done using flow cytometry. Counting 
reiculocytes using automatic method lead to an objective threshold to classify the cell. This 
ensures a higher level of reproducibility in the result. About ten to thitry thousand RBCs are 
studied in the method. Higher counts rate and higher degrres of accuracy is obtained in this 
process. When comparing reticulocyte count done manually along with automated method lot 
of time is conserved as the result is given in lesser than a minute by later method.   
Erythropoietic process and its degree of activation are identified by using retic count and its 
different indices of maturations. It is customary that the retic count is given as the values in 
percentage or as per mil of the RBC counts. 
When severity of the anemia is more the analysis of the reticulocytes counts is challenging. 
When the severity of anemia is high moderately higher and relatively increased reticulocyte 
counts does not mean erythropoetic process is stronger. It could be indicative just of 
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shortening of RBC s life span. It would be is desirable that the absolute reticulocyte 
concentration is given as number rericulocyte per microlitre since capacity of the 
erythropoeisis is provided directly. For an instance if the calculated retic count is 20 percent 
and is said as elevated. Nonetheless, in severity of  anaemia is more  having two  million  
RBCs, 20 percent reticulocyte count would  just  represent 40,000 reticulocyte per micro litre, 
which in the lower range of references. 
 
 
  
Figure 8: Scattergram representing reticulocytes measuring channel 
 
 
 
 
 
Table 6: Comparison of reticulocyte parameters 
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Converting the relative count percentage into cell concentration (RET/microL): 
 
Reference ranges: 
 
Determining reticulocytes count with the help of fluorescence flow cytometry is said to be 
gold standard. 
 
Calculating Reticulocytes index (RI) 
The proportions of the reticulocytes might be elevated relatively when there is an increase in 
actual reticulocyte number or there is a lowering of RBC count. Corrective measure might be 
done with haematocrit value of the patient in reference with the normal hematocrit which is 
0.45 [L/L]. 
The above method of correcting is advised in case of anemia. 
RI = ReT [%] x HcT [L/L] (patients) 
        0.45 [L/L] (standerd HcT) 
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Calculating Reticulocytes production index (RPI) 
The erythropoeitic capacity and marrows productivity is evaluated with the help of 
reticulocyte production index. Physiologically maturing of the reticulocyte occurs inside the 
marrow for three days and within the peripheries for one day. In a situation where there is 
increased synthesis of RBCs many of the reticulocyte could be transferred into the periphery 
leading to the shifting of reticulocyte maturation index.  
Above process causes a predominant rise in the retculocyte in the circulation which usually 
be a representation of an increased erythropoietic performance. This change in duration of 
stay of reticulocyte in the peripheries is known as shift.  
Duration taken for the reiculocyte to get matured in the marrow cavity is directly related to 
the hematocrit. When there is a decline in the hematocrit, there would be an elevation in 
duration taken for maturation. The proficiency of a bone marrow is indicated by the retic 
count by correcting with the following hematocrit dependent factors. 
 
 
 
Table 7: Association of HcT with the maturation time of reticulocytes in periphery 
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Table 8: Interpretating the value for RPI 
 
IMMATURE RETICULOCYTE FRACTION (IRF) 
Indications 
The erythropoeitic proliferation is evaluated with immature reticulocyte fraction which might 
be a first indicator. The percent of immature reticulocyte fraction starts to raise with in some 
hour. But the reticulocyte counts raises 2 to 3 days later. When anemia due to deficient of 
nutrition is being treated using erythropoietin or vitamin supplementation do not show a rise 
in immature reticulocyte fraction would be indicative of absence of therapeutic effect. Added 
to this IRF would assist in classifying anemia as hypoproliferative, normoproliferative or 
hyperproliferative anemia. Along with immature reticulocyte fraction the reticulocyte counts 
had shown to helpful to monitor marrow efficiency and also following up of stem cells 
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transplantation. Successfully transplanted patients with marrow stem cells about 80 
percentage of subjects the Immature Reticulocyte Fraction values attains the 5 percent target 
in early when compared with granulocyte, classical limit of its count being 0.5 x 109 
granulocyte per litre. Added to the routine reticulocytes count, fluorescent flow cytometry 
process helps us to classify reticulocyte as 3 stages. Those stages of maturing are been 
described according to its ribonucleic acid contents - using an analyzer: fluorescence 
intensity. 
 
Reticulocyte maturation 
 
Table 9: Maturation stages of reticulocytes 
 
 
Figure 9: Scatter- gram of the reticulocytes channal 
                                                     
52 
 
 
 
Immature reticulocyte fraction is an addition of MFR and HFR that is immature reticulocyte, 
and refered  as reticulocytes maturation index. 
Immature reticulocyte fraction = MFR + HFR 
Referrence ranges 
Immature reticulocyte fraction RF:  f  1.1 – 15.9 % 
m 1.5 – 13.7 % 
 
Invitro stability of IRF 
Six hour. 
 
 
 
Figure10: Clinical use of IRF 
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RET-He 
Automated counters determine red blood cells, haemoglobin, reiculocyte, immature 
reticulocyte fraction, red cell volume which are quantitative parameters. But qualitatively it 
can be assed with Reticulocyte Hemoglobin equivalent. Reticulocyte haemoglobin equivalent 
offers haemoglobin values in the newly synthesised RBC s. This would offer a real time and 
thus offers real-time informations on ferritin supplied to the erythropoietic process. These are 
specifically helpful to find the difference among the anemia of low serum iron and that of 
anemia due to chronic diseases. In description it is helpful in finding the difference between 
real iron deficient state and sate of „functional iron deficiency i.e problem associated with 
mobilising and utilising iron. 
Determining reticulocyte haemoglobin equivalent could be done on a haematology analyzer 
along regular peripheral smear parameter. Reticulocyte haemoglobin equivalent is not an 
acute phase reactant as against serum feritin and transferin which rises during acute infection 
or inflammation. 
 
 
 
NORMAL HAEMOPOIETIC SYSTEM AND HAEMOPOIESIS 
 
Sites of blood formation
86
 
During the course of development from embryonic to adult life different anatomic sites are 
involved in formation of blood cells. First in early embryonic life embryos yolk sac starts 
producing blood cells. Later blood cells are being produced in the liver and to a little extent 
spleen is also involved. During the course of fetal development between second and seventh 
month of gestation these organs become the major sites of production of blood cells. Bone 
marrow surpases these sites of blood production in later part of gestation and become most 
important and only site after delivery. Despites its production from bone marrow in adult life, 
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the lymphocyte production also occurs in other organs. Soon after delivery in newborn 
production of haemopoietic cells are present in all the cavities of the bones, but  with 
advancing age  the upper shafts of the Humerus, Femur, Pelvis Skull, Spine and bones of the 
thorax are involved. Haematopoietic tissue in adults comprises about one to two litres in total 
volume. 
Haematopoietic stem cells (HSC) which have the potency to develop into cells of different 
lineages are present in large numbers in the bone marrow. Committed lymphoid or myeloid   
(common lymphoid and myeloid progenitors, respectively) are developed from Multipotent 
HSC s. Cells like neutrophils, mast cells, megakaryocytes, erythrocytes and monocytes, and 
also cells like osteoclasts which  are not directly related to the haematopoietic system are 
developed from myeloid lineage of cells. Cells like natural killer (NK) cells, T cells and B 
cells are developed from lymphoid lineage cells.  
 
 
NORMAL BONE MARROW STRUCTURE 
The trabeculae of bone present within the cavity of the bone has interspersed red marrow. 
Marrow also in addition contains specialized connective tissue cells, reticulin fibrils, blood 
vessels, fat cells, nerves and macrophages along with cells of lymphoid and myeloid series. 
Fine reticulin fibrils present as the component within the marrow ensures a supportive frame 
work for the other components of bone marrow. Adventitial reticular cells produce these 
reticulin fibrils that stretch between the endosteum of the bony trabeculae and the vascular 
sinusoids. Sinusoids contain relatively large lumens which are lined by endothelial cells of 
single layer through which arteriolar blood passes through. This is the site where entry of 
newly formed blood cells into the circulation occurs .Nearly half of the extravascular volume 
of the red marrow is made of fat cells and yellow bone marrows which present in the most 
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distal parts of the long bones nearly all of them are fat cells. Since fat cell distribution is 
mostly irregular in red bone marrow, while performing bone marrow specimen adequate 
sample size is needed to find the haemopoietic tissue cellularity.   
 
BONE MARROW BIOPSY:
86,87
 
Bone marrow aspiration has the advantage that the material obtained from the aspiration can 
be used to prepare the smear immediately and can be examined. It has superior 
morphological details than that obtained in histological sections from core biopsy material 
acquired from trephine biopsy. For knowing about the cellularity of haematopoietic elements 
and also to diagnose certain diseases like neoplastic cells or fibrotic material bone marrow 
trephine biopsy is more advantage than aspiration alone. This is because the above materials 
may not be freed from the marrow cavity by suction. From the above discussion we know 
that we have more additive details when both are done, so that the combined data is of 
immense diagnostic value than when either of them is used alone.  
 
 
NEEDLE ASPIRATION BIOPSY OF THE BONE MARROW 
The anatomic sites such as  sternum, iliac crest or anterior or posterior iliac spines are the 
locations from where we can extract a satisfactory bone marrow sample, But since there is a 
danger of injuring a major blood vessel or the right atrium because of misdirected needle 
during the procedure at the sternal site it is now not the favoured site
88
.  
 
The skin over the selected site of aspiration is cleansed with antiseptic solution which may be 
either 70% alcohol or 0.5% chlorhexidine. Then 2% lignocaine is loaded in a syringe and 
infilterated to the skin,subcutaneous tissue and periosteum overlying the site selected for the 
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puncture. Then bone marrow aspiration needle, with a boring movement is passed into the 
cavity of ilium perpendicularly over the posterior superior iliac spine. As soon as we know 
that the needle has passed the bone, stillete is removed and 2 or 5 ml syringe which fits well 
is used to suck up the marrow material as such about 0.3ml of marrow material is obtained. 
This specimen has the variable amount of blood mixed within the marrow material. This 
would be a simple procedure where complications occur rarely except for sternal site 
puncture.
89,90
 
Under the anatomic site of posterior superior iliac spine there lies a large bone marrow 
containing area and from where relatively large quantities of marrow can be aspirated. 
Position needed for the procedure over the posterior iliac spine is a prone position or lying on 
the sides. Since the patient is in lying position while the puncture is done it has the advantage 
over the sternal site that the patient will not visualize the procedure. 
In patients who are all obese where there will be difficulty in locating the iliac spine 
computer tomography guidance is used for performing the procedure.
91
 
 
Bone marrow films 
From the specimen obtained from the aspiration a single drop is delivered on to slides about 1 
cm from one end. This drop should rapidly spread out over the line of contact. Another slide 
is used as the spreader with which the single drop of blood is spreaded along the slide using a 
steady movement of the spreader slide with the hand. An important step is that the slide used 
as a spreader must not be lifted off till the last bit of drop of blood is spreaded over the slide. 
When a suitable sized drop was used the length of the film would be of 3 cms. We should 
make sure that it is important that the film of blood stop short about at least 1 cm before the 
end of the slide. The irregular marrow fragments usually adhere to the slide and most of them 
will be left behind. Then make films 3 – 5 cms in length, with the marrows fragment and the 
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rest of the sample using a glass spread with levelled edges. Wideness of the spreader should 
be below 2 centimeters.  
 
Bone marrow smear films are fixed and Romanovsky dye is utilized for staining purpose as 
that of using in peripheral blood smears. Few other technicians or pathologist add the 
aspirated material in a tube containing anticoagulant and later they prepare smear after 
coming back to the laboratory. By changing the certain maneuvering technicque of the 
spreader slide like its speed, pressure and also the angle at which it is held it is possible to 
alter the film thickness.  The angle of the spreader slide can be adjusted according the 
specimen obtained to get a good quality smear. That is if the sample specimen is obtained 
from polycythemic blood the spreader angle should be narrow and when it is from anemic 
blood spreader angle should be of wider angel so that in a sample derived from polycythemic 
blood the angle between the spreader and slide should be narrower while in patients with 
anaemic blood, the angle should be wider to provide an suitable sample. Microscopic view of 
the smear should show some overlap of red cells in most areas all over the films length to say 
it as an ideal smear. We should be able easily identify the leucocytes all over at most part of 
the film. There would be uneven distribution of leucocytes and that the monocytes and other 
large leucocytes would be moved to the ends and the side of the smear if it has been poorly 
prepared. If a proper slide is not used and the slide has dust and if it is greasy it would 
produce an uneven stripy film with patchy spots.  
 
Manual Staining of Marrow films
92,93
 
Bone marrow aspirate smears are most preferably stained by Wright-Giemsa stains. It is a 
staining solution which is methanol based. This type of stain mostly takes a longer contact 
time for good and acceptable staining of the bone marrow smear. This type of stain requires a 
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buffer step. Even though this stain does not require a separate fixation step because it is 
methanol based stain, we tend to desire to do fixation since it diminishes water artifact which 
tend to occur in humid days and also with aged stains.  
 
When the smears are stained by dip method, the smears are usually fixed by dipping into 
methanol and then it is stained with Wrights–giemsa stain by placing the smear in that stains 
for about 10-15 minutes. Next step the smear is placed in a mixture of stain and a phosphate 
buffer with ph of 6.8 and given time about 20-30 minutes to stain. As soon as staining occurs 
the smears are given a fast rinse with distilled water. Then it is kept for air dry and then 
mounting or cover slipping done.   
 
If the bone marrow smears are stained  with  staining racks, the slide with  marrow particles 
or cover slips, they are swamped  enough with adequate stains  so as slides are covered and 
staining process continues over a  duration of 10-15 minutes. In next step a buffer with a ph 
6.8 is prudently added avoiding overflow then softly mixed by blowing till there appears a 
green metallic sheen. Distilled water is used to thoroughly rinse after it is made to stand for 
period of 20-30 minute.  Before they are mounted, cover slips or slides should be air dried.  
 
When highly cellular marrow is expected the staining times shall be increased. But caution 
should be taken when rack staining method is used. Disproportionate precipitation occurs 
when prolonged time is used because of vaporization of the stain. This can be prevented or 
compensated by topping up of the stain as well as the buffer, however increased rinse time 
must be done. 
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Appropriately stained smears with Wrights and Wright Giemsa stain shall show accurate and 
clearly visible granules of the nucleus and also cytoplasm. Variations in the quality of stain is 
noticed in different batches and also it is reliant on quality control of the producers, method 
of storage and also the shipping environment. It is prudent to have an isolated storage of   
Wrights stain to stain the bone marrow staining which is stocked for duration of at least 6 
months before use. Wrights stain is compared to a good wine because it shows fine quality 
and clarity of final stain as it gets older. 
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Table 10a: Color taken up by different cellular components and inclusions 
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Table 10b: Color taken up by different cellular components and inclusions 
 
 
 
Figure 11: Normal bone marrow picture 
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Table 11: Cell composition of adult bone marrow aspirate 
 
 
 
 
 
Figure 12: Klima Needle 
 
 
The needle is advanced into the marrow cavity with the stylet locked in place. The stylet is 
then removed and a syinge used to aspirate the marrow. 
Cells 95% Range Mean Mean
Myeloblasts 0–3 0.4 1.4
Promyelocytes 3–12 13.7 c 7.8
Myelocytes (neutrophil) 2–13 – 7.6
Metamyelocytes 2–6 – 4.1
Neutrophils 22–46 35.5 32.1 M;  37.4 F 
Myelocytes (eosinophil) 0–3 1.6 1.3
Eosinophils 0.3–4 1.7 2.2
Basophils 0–0.5 0.2 0.1
Lymphocytes 5–20 16.1 13.1
Monocytes 0–3 2.5 1.3
Plasma cells 0–3.5 1.9 0.6
Erythroblasts 5–35 23.5 28.1 M ; 22.5 F 
Megakaryocytes 0–2 0.5
Macrophages 0–2 2 0.4
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Figure 13: Jamshidi Needle 
 
The stylet is in place for advancement through soft tissue and cortex. On reaching marrow, 
the needle is advanced without the stylet to create a core sample. The probe (hooked) is used 
to expel the sample into formalin. 
 
 
 
 
 
 
Figure 14: Bone marrow aspiration 
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Diagnostic indications for upper gastrointestinal 
 
 
The following conditions are the indication for upper GI scopy 
1. When patients present with isolated dysphagia and/or odynophagia and history and 
examination reveals or suspicious of esophageal origin but not pre-esophageal origin. When 
pre-esophageal cause is suspected an thorough ENT examination and work up is needed.
95,96
 
2. In patients presenting with persistent nausea or vomiting presenting for greater than 48 
hours, after excluding acute intestinal obstruction and other non gastro intestinal cause. 
3. It is advised in patients with dyspepsia who are all aged more than 45 years with or without 
signs and symptoms such as dysphagia, weight loss, anemia or other warning symptoms. In 
patients with age less than 45 years it is advised for suspecting H.pylori infection and 
treatment has failed to improve the symptoms or the symptoms relapse.
97,98
 
4. It is advised  for evaluation of  anemia  of long duration and  or  lower  iron storage  state 
when there is suspicion of an upper GI cause.
99,100
 
5. Upper GI scopy is advised strongly as preliminary line of investigation in acute intestinal 
bleed which probably comes from the upper gastrointestinal tract (haematemesis or melena). 
It should be make sure that endoscopy is performed rapidly and in any event not exceeding 
24 hours after the episode of bleeding. Therapeutic procedure needed can be performed at the 
same time during the scopy. Scopy shall be repeated when there is persistence of bleed or 
when the previous scopy  or colonoscopy was inconclusive.
101
 
6. Gastro-oesophageal reflux disease in patients aged more than 50 years or with warning 
signs of bleeding, dysphagia, weight loss or anemia or if there is no relief of symptoms after 
adequate treatment or relapse of symptoms when the treatment is withdrawn. Upper 
gastrointestinal endoscopy is indicated, after non- gastrointestinal origin has been eliminated, 
if there are atypical symptoms which may be related to gastrooesophageal reflux (nocturnal 
                                                     
65 
 
cough, asthma, pain mimicking angina, hoarseness, burning sensation in the pharynx, ear 
pain).
102
 
7. Barrett‟s oesophagus - To establish a diagnosis of barretts esophagus we need to do 
endoscopy as well as biopsy which would show dysplasia. Second biopsy is needed to be 
done 2-3 months after initial one and in the intervening time treatment with antisecretory 
drugs should be given. Regular follow up and repeated endoscopic monitoring is mandatory 
depending on the degree of dysplasia and cancer risk of the patient. When there is intestinal 
metaplasia without dysplasia repeat endoscopy along with multiple biopsies every two to 
three years is necessary. In patients with low grade dysplasia in biopsy we need to perform 
endoscopy every six months for one year and then every year. Monitoring can be stopped if 
there is high grade dysplasia or when it seems improbable that continued monitoring will 
increase survival.
103
 
8. Peptic ulcer: The following are the patient population in those with typical or atypical 
symptoms of ulcers, upper gastrointestinal scopy is advised as the first choice 
• in all subjects when their  age is beyond 45 years with typical or atypical ulcers; 
• in subjects when their age is below 45 years who has warning signs or symptoms or who 
has H.pylori positive status or treatment failure. 
Multiple biopsies would be done consistently in patients with gastric ulcers. A control 
endoscopy might be done as part of follow-up of a gastric ulcer. When the patient is of age 45 
years, persistence of symptoms even after good treatment, if there is any difficulty in 
identification of biopsy specimen or the earlier appearance in endoscopy is not usual. In 
patients with drug induced ulcers UGI scopy is advised when there is persistence of 
symptoms even after stopping the drugs or if there is a clinical situation the drug could not be 
withdrawn
97,98
. 
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9. Upper gastrointestinal endoscopy is advised as a diagnostic procedure when portal 
hypertension is a diagnostic possibility and also to search for varices in esophagus and 
stomach in the patients who has cirrhosis of liver. When the initial endoscopy does not show 
varices in patients with cirrhosis regular follow up every two years with endoscopy is 
suggested. Check endoscopy is advised in patient who has undergone endoscopic treatment 
for esophageal varices.
104
 
 10. Duodenal biopsy
105
: Following  circumstances warrant to undergo a duodenal biopsy  
along with UI scopy  
• in patients with iron-deficiency anaemia in whom a specific cause can not be  made out. 
• in subjects having low folate levels, this is usually  combined with gastric biopsy 
• in subjects with deficiency of other nutritional factors 
• in patients who are under evaluation for chronic diarrhoea; 
• in patients with  dermatitis herpetiformis; 
• to asses the therapeutic  response to a gluten- free diet in coeliac disease; 
• when a specific parasite is strongly suspected to be infested and stool examination is 
negative for the specific organism  (lambliasis, strongyloidiasis).  
 
THE ENDOSCOPY PROCEDURE 
Patient planned for an upper gastroduodenal endoscopy, informed consent is obtained, are 
kept nil by oral for about 8 hours. The patient is made to lie on his left lateral side for the 
procedure to be performed. It would take about 20 to 30 minutes for the procedure to be 
finished. Time depends on whether biopsy is taken or not
106,107
. First topical lignocaine is 
applied to the throat through spray technique or else patient is made to gargle with the local 
anaesthetic solution. This makes the throat to feel numb. Then between the teeth a plastic 
mouth guard is placed so that it avoids any damages being done to the dentition as well as to 
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the instrument. The endoscope also named to be gastroscope is a flexible tube that has the 
size of finger. Source of light and a lens is present in the scope so as to enable the scopist to 
visualise the epithelium of the upper intestines mostly in a television screen. The endoscope 
has a lens and a light source that allows the endoscopist to see the inner lining of the upper 
gastrointestinal (GI) tract, usually on a TV monitor. The endosope is passed oraly between 
the teeth protected by the mouth guard and patient is instructed to make swallow movement 
as soon as the tip of the scope reaches the oropharynx enabling smooth passage into the 
esophagus. In overtly anxious subjects mild sedation can be offered. 
Another method is to pass a thin scope through the nasal cavity to enter the esophagus. This 
is called as trans nasal approach
108
. Topical anaesthetic agent is applied to the nostrils before 
the procedure. Along the scope air is smoothly presented into the intestines so as to dilate the 
oesophagus, stomach, and small and large bowel so that the scope is able to pass via those 
regions and improves the visualisation the scopist. Mild discomfort would be experienced by 
the subject while injecting air into the stomach and intestine. 
 Patient may feel fullness of the stomach which will be relieved after belching. Normal 
breathing is not interfered with the procedure. Patients are instructed to be relaxed and asked 
to take slow and deep breaths during the procedure. 
 
RECOVERY FROM ENDOSCOPY 
Patients are allowed to stay for about an hour or less for observation. This is usually for 
action of the sedative drugs to wear off. If sedative drug is been used patient may feel tired 
for short duration and also have mild concentrating difficulty. Such patients are advised not 
to drive vehicle or resume their work on the day of procedure. After the procedure patient 
might have minimal sore throat, but patient is able to tolerate oral feeds soon after the 
                                                     
68 
 
procedure. They might also have mild bloating sensation of the abdomen if air has passed to 
the intestine. 
 
ENDOSCOPY COMPLICATIONS 
Complication of Upper endoscopy is very minimal or almost negligible because it is a simple 
procedure. Following are few complications while doing an endoscopy  
 Inhalation of food particles or gastric secretions.  
 Reactions to the sedative medications. 
 Biopsy site bleed or bleed from site o where polyp is removed. Though these Bleed 
are smaller in amount and usually gets arrested by itself or able to control with ease. 
 Injury or rupture of the esophagus, stomach or duodenum, but usually rare. 
Patients are advised to report immediately if they develop the following symptoms: 
 Intense pain abdomen  
 Abdomen distention 
  Recurrent and severe vomiting 
 Fever  
 Finding difficult to swallow or intense painful throat 
 Feel of crunch below the skin  over the neck area. 
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DUODENAL BIOPSY 
 
Tubular structure which is present as continuation between stomach and the cloaca develops 
intestines. The initial portion of this tubular structure gives rise to the portion of the intestine 
extending between distal part of duodenum and proximal part of the ileum. The distal part of 
the ileum and initial 2/3 rd of the transverse colon is developed from the little distal part of 
the tubular structure. With the growth of the embryo the tubule of endodermis gives rise to 
the epithelial lining. Further during development of the embryo at 9 to 10 week of gestation 
stratified squamous type of lining is converted into simple columnar typo of epithelium. 
Villus forming process starts at ninth week. About five days prior to delivery the epithelial 
lining differentiates morphologically into its finale structure. About during the middle of the 
gestational age initial stage of lymphatic cells begins to appear. In about sixteenth week of 
gestational age aggregation of T-cell and B-cell occurs as aggregates of T and B cells form 
primary Peyers patch. By the 19th week of gestation fully developed peyers patches appear.  
 
HOW TO EVALUATE SMALL INTESTINAL BIOSY 
In assessing any biopsy tissue obtained from the duodenum clinico-pathological relation is 
needed to diagnose a disease. Adequate clinical data should be provided to the pathology 
department by the treating physician in order to make good assessment. Pathologist should go 
read through the request form in order to determine the significant feature of the patient 
clinically and also to clearly know about the sites from where the specimen was taken.  
Data to be furnished to the pathology lab are as follow: 
1. Age and sex of the patient 
2. Signs and symptoms, site of the biopsy, endoscopic findings, radiological findings 
3. Clinical diagnosis or impression 
4. Medical and surgical history 
                                                     
70 
 
5. History of taking drugs or alcohol 
6. History of immunosuppression 
7. Findings of previous biopsies 
Routinely taking biopsies from the duodenum for whatever the scopy indication might be or 
whatever might be the appearance of the epithelium macroscopically is  a  bit  in divisive
109
. 
But on the other side routinely taking biopsy from the duodenum could give an unanticipated 
finding pathologically, that might have chief association clinically. But the hazard of 
performing anaesthesia which could have been averted and also problems of procedure in 
getting specimen from seemingly appearing regular mucosal surface is in upsurge. 
 Over all, the cost benefit ratios might not be in favourable position.  Nonetheless,  it has been 
noted in most of the trials that unanticipated pathological features are seen in the specimen 
taken routinely from the duodenum
110,111
. One research done with cohort of children 
disclosed  that taking tissues from the duodenum yielded abnormal pathological features in 
about 17% of the children
110
. Unpredicted pathological features are found to be reported in 
various research papers like giardiasis, minimally inflamed mucosa chronically in the 
lammina propria, more number of plasma cells in the mucosal lining in the specimen 
obtained from the stomach related H.pylori colonisation. In one research upsurge is noted on 
the intraepithelial lymphocytes (IEL) counts, without a positive anti-endomysial antibody and 
also be related to the primary symptomatology. Above research paper stated that more 
frequent i.e. in more than half of the subjects the reason for endoscopic procedure was to 
evaluate anemias. This paper gave statistical significance saying that  normally appearing 
mucosal surface macroscopically may show findings of certain features pathologically
110
. It 
can be said  the assessment of the specimen obtained routinely from the duodenum might  be 
of valued procedure in aiding and diagnosing a disease pathologically which was not 
suspected in subjects with no symptoms or else whom do not have typical symptoms
110,111
. 
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The numbers of biopsies taken simultaneously from the duodenum were inconstant and also 
the sites from were taken. Few researchers recommend to take at least 3 samples of duodenal 
tissues distally 
112
. Due to the involvement of mucosa is restricted and are irregular, many 
number of samples should be taken to lessen the chance of under-diagnosis and or 
misdiagnosis
113
. This type of situation arises in many conditions. Destruction of the 
duodenum brought about through glutens appears to begin in the bulbs of the duodenum. 
Then later it slowly progress to involve the other duodenal parts and initial jejunal portion.  
Subsequently, the position and the quantity of the tissue specimen would play a significant 
role in making an exact disease process of GSE
114
. In Gluten sensitive enteropathy pathology 
of the duodenum might be in patches that too particularly in childhood population
114
 and also 
atrophied villi might be seen adjacent with or concur the atrophied mucosa or the  mucosal 
surface without any abnormality. The mucosal surface of the bulbous part of the duodenum 
alone is diseased when the specimens were stained with special stains. Analysing with histo-
chemical staining are mostly carried out to identify mico-organisms and the component of the 
cells. 
 1. Periodic acid Schiffs stains for identifying macrophage in Whipple‟s diseases, fungal 
infection, metaplasias of mucosa of the stomach and duodenal inflammation and also the 
stability of the brush-border. 
2. Di-astase periodic acid Schiffs or methenamine silver stain are used in Cryptococcal  
neoformens. 
3. Wade-Fite, Ziehl Nielsens or Aouramine stains to stain mycobacteriums. 
4. Warthin Starrys stains for microsporidium. 
5. Iron hematoxylin countar stains in tri-chrome techniques, Giemsas stain, toluedine blue for 
Giardia. 
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6. Immuno-peroxidase stain for cytomegalo-virus. Immuno-histo-chemistry is applied to see 
CD-3, CD-4 and CD-8 in Gluten sensitive enteropathy or refractory sprues. 
 
 
INTERPRETATING TISSUE BIOPSY OF DUODENUM 
 
EVALUATING THE ARCHITECTURES 
Visualising with Low power magnifying lens of the microscope would provide evidence 
about the gross look and the structure of the mucosal surface of the duodenum. A well 
oriented biopsied tissue must be having at least four to five sequentially long, villous 
structures which have distension beginning in the basal portion extending to its tips. The 
architectural structure of the villi might show varied range of alteration in the morphology 
among different cohorts. Morphologicaly Villi comprises various shapes such as fingers like, 
leaves like, tongue like or ridges. Duodenal mucosal surface commonly has branching villous 
and villous with glued tips or the mixer of the above two.  
 
Morphologically the villi structure varies with location of the patient in geography. Villous 
structure  seen at  temperate area might be of long and finger like structures, but in regions of 
tropics villous might be  alike  leaves or ridges in the proximal portion and alike finger  in the 
distal part
115
. Normally V:C ratios appears approximately between 3 to 5:I. When there is 
shortened and blunted villous structures causing flattened mucosa it is called as atrophied 
villi. This atrophied villi are graded according to the V : C ratio. It is called total when it is 
between 0 to 1 : I  or else in-complete when it is between 1 to 4 : I 
116
. Atrophying of villi is 
said to be not of any specific pathology but could be of reaction to diverse injury. The 
pathogenetic mechanism involved could either be connected to the elongated crypts caused 
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by hyper regeneration in the mitotic activity of cellularity of the crypts as seen in gluten 
sensitive enteropathy or it can occur because of hypo renewal of cell which means low 
mitosis activity in the cells producing condensed cryptic structures that might be seen in 
patients who are starved or those are on TPN
117
. Multiplication of the crypts cellular structure 
is initiated by activation of T cells. As a result of which active CD – 4  T cell are responsible 
in  maintaining the mucosa with normal structure
117
. 
 
Tissue from mucosa of the duodenum gives rise to particular issues in arriving at a decision. 
The villous structures are short and thick  in duodenum when compared with that of jejuna 
mucosa specifically in the mucosa over the Brunner gland
118
 or lymph cell follicle. 
Henceforth  diagnosing atrophied villi in bulbous part of duodenum is tough
113
. In whipples 
diseases and in MAC infection blunting and shortening of villous structures occurs or seen as 
atrophied because penetration with macrophage cells or densely infiltrating plasma cell and 
centrocytes alike lymphocytic cells or pleo-morphic lymphocytic cells. 
In above diseases, the superimposing epithelial layer would be normal, cryptic structures are 
exempted also the Intraepithelial lymphocyte counts are in usual range. Cryptic hyperplasias 
might be due to repairing effect or re-creating process
119
. It is categorised by lengthening of 
the cryptic structure, reduced C : V ratios and more mitotic activity because of enlargement in 
the proliferating section of the crypts from its base extending through the entire height. 
Evaluating cryptic hyperplasia in disease of gluten sensitive enteropathy is usually tough, 
particularly while there is preservation of the structure of the villi. K  i  67 indeces
120
 would 
be supreme marker for sensitivity to asses cryptic hyperplasia. Epithelial surfaces constitute 
of  columnar cell of absorbing type called entero-cytes and cells  which produces mucous 
secretions called the goblets cell. The enterocyte cells characteristically have the nucleus at 
the base and are regularly allied. Periodic acid schiffs stain positivity is seen on the lumen 
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surface of the entero-cytes. Enterocytic cells have the goblets cell dispersed in between them. 
Alcain blue positivity is seen because of mucain in the goblet cell. Paneths cell of the crypt‟s 
are indicated  by brightly esinophilic, supra nuclear granular structures in the cytoplasm. 
Cryptic endocrine cells are seen singly or in aggregated form. Distinct from the paneths cell 
endocrine cells are seen at the base of the cells i.e below the nucleus. Places among the 
individual villous present over epithelial surfaces should be in between the villi on the surface 
epithelium have to be prudently checked to discount the existence of Giardia. 
Cautiously inspecting the epithelial upper layer particularly over villous tip is mandatory 
since  few of the research authors had said that  C D 3 lymphocytic intraepithelial cells are 
distributed mostly on the top, suggesting  gluten sensitive enteropathy
119,121,122,123
.  
In addition, plentiful protozoas which infects small intestine like microsporidium, 
cyclosporum and isosporum  preferentially present at the enterocyte in the villous tip  and the  
epithelial surface  might be showing  disruption of the architecture and disintegration 
focally
124
. They might display non specific change of degeneration like cytoplasmic 
vacuolization or gastric-metaplasia. 
The lamina propria frequently contains plasma cells and lymphocytic cells with very 
infrequent appearence of eosinophills and macrophage cells. Secretion of immunoglobulin A 
into the lumen of the intestine is by the plasma cell present in the lamina propria. Mucosa 
associated lymphoid nodule are spreaded all over the mucosal surface and accumulate into 
visible Peyer‟s patches. 
An increase in thickness of the mucosa can be  a consequence of edema and a raise  in  the 
count of various inflammatory cells
125
. The bulk of the lamina propria is enlarged and would 
be doubled when comparing to that of normal mucosal layer in lesions of flat destruction seen 
in gluten sensitive enteropathy
125
. 
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In Biopsies obtained from duodenum of subjects having a disease of dermatitis-herpatiformis 
the escalating distension seen in lamina-propria ensues with permeation of inflammatory 
cells. Architectural change in the mucosa advances from type 1 through type 3 finally 
becoming even. Undoubtedly, edema and infiltrating neutrophils into the lamina-propria are 
primary features found to seen along with enlarging crypts. This might be isolated 
phenomenon indicating changes in the architecture
125
. An acute inflammatory change could 
be much strong which might  imitate as of  peptic ulcer
119
. The elevation of neutrophill 
counts is reliant over the doses of the gluten exposure
125
. 
 
Few of the times eosinophils are noticeable and  found infiltrating epithelial layer in gluten 
sensitive enteropathy
119
 and  with allergic conditions  associated  foods
126,127
. The lamina 
propria might be populated by Cryptococcal organism or by enlarged macrophage infiltration 
as of in infections with mycobacterium infection, leischmaniasis or Whipples diseases. 
Inclusion bodies associated with viral infection like cyto-megalo viruses are seen within the 
cells of endothelium, fibroblastic stromal cells, in brunner glands and also in the smooth 
muscular cell. 
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MATERIALS AND METHODS 
 
This is a prospective and descriptive study which was done over a period of 12 months on 50 
patients with age ≥15 years who were admitted with macrocytic anemia in PSG hospitals, 
Coimbatore. 
 
 Macrocytic anemia was diagnosed in patients with  
1. A mean red blood corpuscular volume >95 fl and 
2. Anemia with a hemoglobin of 
a. < 13 gm/dl in male patient 
b. < 12 gm/dl in female patient 
 
Inclusion Criteria 
Patients above the age of 15 years with macrocytic anemia. 
 
Exclusion Criteria 
Patients with decompensated liver disease, chronic kidney disease, Hemolytic anemia, 
Hemorrhagic disease. 
Post splenectomy and pregnant patients. 
 
 
Detailed history was obtained from the patients. Full and methodical clinical examination 
was done in all patients. Complete information was obtained regarding alcohol intake, drug 
intake, thyroid disorder and other comorbid illness. All patients were investigated with a 
complete haemogram which includes estimating hemoglobin level, red blood cell indices 
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(MCV, MCH, MCHC), red cell distribution width (RDW), total leucocyte count, differential 
leucocyte count, platelet count, reticulocyte count, and examination of peripheral smear. 
Whenever the patients showed the features of megaloblastosis like occurrence of 
hypersegmented neutrophils or macro ovalocytes bone marrow aspiration and biopsy was 
done after obtaining the consent. Liver function tests were done in patients who presented 
with icterus. Serum TSH was done to rule out Thyroid dysfunction. 
Patients fasting vitamin B12 and folic acid were measured. 
An upper gastrointestinal endoscopy with biopsies from deep duodenum was done in patients 
with megaloblastic anemia who consented for the procedure. 
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RESULTS 
 
In our study population of fifty patients presenting with macrocytic anaemia 34 were male 
comprising about 68% and 16 were female comprising about 32%. The mean age of male and 
female were 53.15 ± 15.89 and 54.37 ± 16.58 respectively. Majority of the population belong 
to the age group above 40 years, both in males and females. 
 
Sex n Percentage 
M 34 68% 
F 16 32% 
Table12: Sex distribution 
 
Sex M F 
Age 15 – 25 3 2 
Age 26 - 40 4 1 
Age 41 - 60 17 7 
Age > 60 10 6 
Percentage 68 % 32% 
Table 13: Age distribution 
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Figure 15: Age and sex distribution 
 
3
4
17
10
2
1
7
6
Age 15 - 25 Age 26 - 40 Age 41 - 60 Age > 60
Age and Sex distribution
Male Female
                                                     
80 
 
In our population of patients, 58% (n=29) of the patients presented with fatigability, 16% 
(n=8) with chronic diarrhoea and 26% (n=13) with other symptoms like short pyrexia etc. No 
patient had bleeding tendencies or features of nervous system involvement. There were about 
6 vegetarians with others consuming mixed diet. Five patients gave history of consuming 
alcohol. 
 
 
Symptoms n Percentage 
Fatigability 29 58% 
Diarrhea 8 16% 
Others 13 26% 
Table 14: Presenting symptoms 
 
On clinical examination, pallor was noticed in all patients in various degrees. Icterus was 
seen in 10 patients, hyperpigmentation of the kuckles in 7 patients. Organomegaly was 
noticed in 2 patients among them one had hepato-splenomegaly and one had splenomegaly. 
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Figure 16 Clinical findings 
 
In the study population 38 patients had low vitamin B12, 5 patients had low levels of both 
folate and vitamin B12 and 2 patients had low folate level alone. In the remaining five 
patients in whom both vitamin B12 and folate were normal, two had history of drug 
exposure.  
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Figure 17: Etiology of macrocytic anemia 
 
Among the remaining three, first patient a vegetarian presented with pancytopenia and 
macrocytosis. Bone marrow smear showed picture of megaloblastic anemia. Upper GI 
endoscopy showed scalloped duodenal folds, but duodenal biopsy showed non-specific 
inflammatory changes. Blood counts improved after treating with parentral vitamn B12.  
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Second patient a vegetarian presented with pancytopenia, macrocytosis, and hypersegmented 
neutrophils in peripheral smear. Bone marrow smear was suggestive of megaloblatic anema. 
Upper GI scopy showed scalloped duodenal folds and biopsy was suggestive of tropical 
sprue.  Blood counts improved with supplementation of Vitamin B-12.  
Third patient also a vegetarian presented with pancytopenia and macrocytosis in peripheral 
smear. Hemolytic work up was negative. Bone marrow smear was suggestive of 
megaloblastic anemia with ineffective erythropoiesis. Upper GI scopy showed scalloped 
duodenal folds, biopsy showed peptic duodenitis.  
The hematological study at the starting point revealed 20 patients presented with anemia 
alone, 6 patients with bicytopenia (low haemoglobin and low platelets) and remaining 24 
patients presented with pancytopenia.  
The mean haemoglobin was 7.1, mean MCV was 115 and mean red cell distribution width 
(RDW) was 22.71 among the fifty patients. 
 
Hematological Parameter Mean ± SD 
Hemoglobin 7.1 ± 2.5 
MCV 115.1 ± 10.3 
RDW 22.71 ± 6.2 
Total Count 4775 ± 2643 
Platelet Count 123686 ± 100097 
Table 15: Hematological parameters 
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 Male Female 
Pancytopenia (n = 20) 17 3 
Bicytopenia (n = 6) 4 2 
Table 16: Sex distribution in patient presenting as pancytopenia and bicytopenia 
 
The mean haemoglobin was 5.62 and mean platelet count was 49933 in the patients presented 
with bicytopenia. In the patients presented with pancytopenia the mean haemoglobin was 6, 
mean total white cell count was 2830 and mean platelet count was 51250. 
 
Hematological Parameter in Bicytopenia Mean ± SD 
Hemoglobin 5.62 ± 2.17 
Platelet Count 49933 ± 26070 
Table 17: Hematological parameter in patients with bicytopenia 
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Hematological Parameter in Pancytopenia Mean ± SD 
Hemoglobin 6 ± 1.99 
Total Count 2830 ± 488 
Platelet Count 51250 ± 32309 
Table 18: Hematological parameter in patients with pancytopenia 
 
Hemoglobin MCV 
Male Female 
< 6 113.56 ± 7.83 
12 6 
> 6 115.96 ± 11.39 
22 10 
Table 19: Mean MCV and degree of anemia 
 
When values of MCV were compared with the  degree of anemia using Independent student 
T test it was found that there was no correlation (p=0.4) between the degree of anemia and 
the level of macrocytosis.   
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Vitamin B12 level Mean MCV ± SD 
< 100 n = 28 116.69 ± 10.89 
101 – 190 n = 15 112.20 ± 6.83 
> 190 n = 7 114.92 ± 12.50 
Table 20: Level of vitamin B12( p/ml)  and MCV 
 
When the different ranges of levels of serum vitamin B12 were compared with mean of the 
mean corpuscular volume using Anova test, no correlation was found (p=>0.5). 
Among 20 patients presented with pancytopenia, 16 had their serum vitamin B-12 lower than 
normal with mean 64.37. Among 6 patients presented with bicytopenia, all had their serum 
vitamin B-12 lower than normal with mean 76.83. Among 24 patients presented with anemia 
21 had serum vitamin B-12 lower than normal with mean 98.24. 
 
 
 
Vitamin B-12 Mean ± SD 
Pancytopenia 64.37 ± 31.41 
Bicytopenia 76.83 ± 33.36 
Anemia 98.24 ± 44.88 
Table 21: Level of vitamin B12 (p/ml) in patients with pancytopenia, bicytopenia and 
anemia 
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When the various levels of low serum vitamin B12 were compared with presentation of 
patient with anemia, bicytopenia or pancytopenia using Anova test there was was no 
correlation (p=>0.5). 
 
Figure 18: Hematological presentation of patients with low Vitamin B-12 
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Figure 19: Percentage of vegetarians and non-vegetarians in low serum vitamin B-12 
group  
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Figure 20 a             Figure 20b  
 
 
Figure 20c 
Figure 20 a, 20b & 20c: peripheral smear features in our patients 
 
On examining the blood peripheral smear hypersegmented nuetrophils or macroovalocytes 
was seen in 25 patients suggesting megaloblastic erythropoiesis.  
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Figure 21a       Figure 21b 
Figure 21a & 21b: Bone marrow aspiration smears in one of our patient 
 
Among 50 patients, 29 patients who gave consent for bone marrow procedure underwent 
marrow aspiration and smear study and was found that all had megaloblastic erythropoiesis in 
their marrow.  
 
Hypersegmented / Macro-ovulocytes 
Megaloblastic bone marrow 
Yes No 
Yes 25 0 
No 4 0 
Table 22: Megaloblastic features in peripheral smear and megaloblastic bone marrow 
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Different types of morphologically abnormal cell in the peripheral smear study include 
hypersegmented neutrophils, anisocytosis, macroovalocytosis, tear drop cells and nucleated 
red blood cells. These findings had strong association with megaloblastic erythropoesis of 
marrow. 
In 5 patients who had not shown any features with hypersegmented neutrophils or 
macroovalocytes in the peripheral smear, 4 patients had low vitamin B12 and one had low 
folate levels. 
Icterus was noticed as a principal finding in 10 patients. The mean of the total serum bilirubin 
in those patients was found to be 3.16 and all had increased indirect bilirubin. 
Drug intake was seen in 3 of the patients. One was on sodium valproate for movement 
disorder and had associated low vitamin B12 and presented with pancytopenia. Among the 
other two in whom vitamin B 12 was low one was on phenytoin and sodium valproate for 
seizure and presented with pancytopenia. The other patient was on phenytoin for seizures and 
presented with anemia alone. All the three drug exposed patients had megaloblastic bone 
marrow. 
Number of patients who had features suggestive of megaloblastic anemia in peripheral 
smears (macrocytosis, ovulomacrocytosis, aniso and poikilocytosis, hypersegmented 
neutrophils) was 25. All these patients had undergone bone marrow aspiration. Their bone 
marrow smears confirmed megaloblastic picture. Also four patients whom do not show 
typical megaloblastic peripheral smear picture showed megaloblastic bone marrow on 
aspiration smear. 
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Among the study people thirty four consented for upper GI scopy. Twenty six of them 
showed duodenal finding of either scalloped duodenal folds or folded duodenal margins. 
Other showed features of erosive gastritis, atrophic gastritis or antral gastritis. One had 
external gastric impression and the other had gastric polyp. 
 
 
Figure 22: Endoscopy findings 
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Among twenty six patients in whom there were abnormal duodenal features fifteen showed 
features suggestive of tropical sprue in deep duodenal biopsy. Two patients who had normal 
duodenal findings had features of tropical sprue in biopsy. 
 
Positive duodenal findings 
Tropical sprue 
Yes No 
Yes 15 11 
No 2 5 
Table 23: Positive duodenal endoscopic findings and tropical sprue 
 
When positive finding in the duodenum during upper GI scopy and the diagnosis of tropical 
sprue with biopsy features were compared there was no statistical significance (p=0.2). 
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Figure 23: Duodenal biopsy findings 
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Among 7 patients presented with chronic diarrhoea 4 underwent UGI scopy and duodenal 
biopsy and all were found to have tropical sprue. 
There were total of 13 males and 4 females with tropical sprue. 
 
 Male Female 
Tropical Sprue 13 4 
Table 24: Genderdistribution in tropical sprue 
 
 
                            
Figure 24a        Figure 24b 
Figure 24a &24b: Findings in the biopsy from the duodenum in our patient 
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Figure 25: Percentage of Tropical sprue in patients with positive duodenal findings in 
Endoscopy 
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DISCUSSION 
Macrocytic anemia has variable etiological factors.In our study population 76% had vitamin 
B12 deficiency,10% had deficiency both folate vitamin B12 and 4% each had folate 
deficiency and drug induced macrocytic anemia. McPhedran in his study on 100 consecutive 
patients, reported Low B 12 and low folate levels with megaloblastic erythroid cells was 
commonest reason  which leads to macrocytic anemia
2
 .This was consistent with our study.  
But on the other hand in the study conducted by Colon-Otero excessive alcohol intake  was  
commonest  reason for macrocytosis followed by  low vitamin B 12 and low  folic acid levels 
128
. In another study conducted in the year 2000 by Savage and co workers, reported, 
commonest reason for macrocytosis was drug exposure. Following it was the alcoholic liver 
disorders and reticulocytosis. 
 
Study Common cause identified 
Our study Megaloblastic 
McPhedran Megaloblastic 
Colon-Otero Alcohol abuse 
Savage et al Drug, Alcohol abuse 
Table 25: Causes of Macrocytic anemia in various studies 
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We know there are variable clinical presentation of Vitamin B12 deficiency associated with 
megaloblastosis in the bone marrow, macrocytosis in the peripheral smear and a raised MCV. 
In our study population major presenting symptom was fatigability which was found in 58% 
of the patient and in about 16% of patient chronic diarrhoea was the presenting symptoms. 
No patient was presented with bleeding manifestation or had neurological symptoms. 
 In a study conducted in 100 patients by Tejas Shah and Tarun Rathod 96% presented with 
symptoms of fatigue, 30% and 42% of the study population had psychiatric and neurological 
symptoms, 2% had diarrhoea
77
. In another study by Salma Haq et al in a population of 80 
patients 84% had fatigability, 34% had bleeding manifestation and no patients had 
neurological symptoms
12
. In a study conducted by Vineetha Unnikrishnan et al in a 
population of 60 patients 91.7% presented with fatigability, 36.7% had bleeding 
manifestation, 1.7% with diarrhoea and 10% with neurological symptoms. 
 
Figure 26 Comparison of presenting symptoms in various studies 
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In our patient population male and female percentage is 68 and 32 respectively. Male to 
female ratio was 2.1 : 1.  About 80% of the patients were of the age above 40 years. Among 
them 48% were of the age between 41-60 years and 32% were above the age of 61 years. 
In comparison, Salma haq et al study showed 17.6% of patients in age group 41-60 and 
12.5% in age group above 60 years. In contrast to our study this study also included patients 
below the age 15 years. 
In studies conducted in Caucesian population and patients in china, megaloblastic anaemia 
was accounted in old age group patients with equal sex distribution or predominanatly males. 
But our study showed highest incidence among the patients between the age the age group of 
10 and 30 years i.e (48% of patients) and there was a preponderance of women (71%). 
 
Figure 27 Comparison of age group with Tejas Shah et al 
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Comparing gender ratio with other studies, Vineetha Unnikrishnan et al had more Male : 
Female ratio as that of our study. But studies done by Tejas Shah et al and Uma Khanduri et 
al showed female predominance. 
Study Male : Female ratio 
Our study 2.1 : 1 
Tejas Shah et al 1 : 1.5 
Uma Khanduri et al 1 : 1.4 
Vineetha Unnikrishnan et al 1.8 : 11 
 
Table 26: Gender distribution in various studies 
 
In our study population clinical examination revealed pallor in 100%, icterus in 20%, skin 
hyperpigmentation in 7% and organomegaly in 4% of the population. 
In the study by Tejas Shah et al 63% had pallor, 32% had skin hyperpigmentation and 12% 
had icterus.In the other study by Salma Haq et al 84% had pallor, 28% had jaundice and 
hepatomegaly and 48% percent had splenomegaly. In a study by Vineetha Unnikrishnan 35% 
had jaundice, 31.7% had splenomegaly, 28.3% had hepatomegaly and 23.3% had skin 
changes. 
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Figure 28: Comparison of presentation of patients with Pallor 
 
 
Figure 29: Comparison of presentation of patients with Icterus 
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Figure 30: Comparison of presentation of patients with Hyperpigmentation 
 
 
Thus when compared to the above studies our study population had lesser percentage of 
patients with jaundice, organomegaly and skin changes, and have more patients presenting 
with pallor. 
 
On presentation in our study population 48% had pancytopenia, 20% had anemia and 12% 
had bicytopenia. In the study by Tejas Shah et al reported same percentage (48%) of patient 
with pancytopenia. In  another  study by Uma Kandhury et al  62%  of pancytopenia.Salma 
haq et al study reported pancytopenia  in 41% and bicytopenia in 60% . 
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Figure 31: Comparison of presentation as Pancytopenia 
 
 
 
Figure 32: Comparison of presentation as Bicytopenia 
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Table 27: Comparison of hematologic parameters of the study population at presentation 
 
 
Hematological Parameter 
Our Study 
n=50 
Vineetha Unnikrishnan 
n=60 
Total WBC count 
4775  ±  2643 1043 ±  2813 
Platelet count 123686 ±  100097 109000 ±   110000 
Table 28: Comparision of hematological parameters 
 
 
Hematological 
Parameters 
Our Study  
n=50 
Vineetha 
Unnikrishnan  
n=60 
Gulam Shah  
n=113 
Hemoglobin 7.1 ±  2.5 5.6 ±   2.12 11.32 ±   2.15 
Mean corpuscular 
volume 
115.1 ±  10.3 106.5 ±   9.59 100.64 ±  19.77 
Red cell 
distribution width 
22.71 ± 6.2 20.7 ±   6.06 12.5 ±   2.5 
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In our study 36% patients presented with haemoglobin of less than 6 and 64% presented with 
haemoglobin more than 6. In comparison study by Vineetha unnikrishnan et al the percentage 
was 63.3% and 36.7% respectively.  
 
Hemoglobin values 
Mean corpuscular volume 
Our study Vineetha Unnikrishnan 
n = 50 n = 60 
< 6 
113.56 ± 7.83 107.7  ± 8.64 
n = 18 n = 38 
> 6 
115.96 ± 11.39 104.5 ± 10.97 
n = 32 n = 22 
Table 29: Comparison of haemoglobin and Mean corpuscular volume  
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In our study 91% of the population were on mixed diet and 9% were on vegetarian diet. In 
our study   non vegetarians were commonly affected. In concordance with our study, other 
study conducted by Iqbal SP et al showed Vitamin B12 deficiency in 94% of non-
vegetarians. 
 
 
Figure 33: Non–vegetarians in various studies 
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But the data collected from Andrews L et al and SR Kankonkar et al it is known that vitamin 
B12 deficiency is higher in vegetarians compared to non-vegetarian. 
  
 
Figure 34: Vegetarians in various studies  
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In our study hypersegmented neutrophils were observed in about 50%. But Khanduri and 
Sharma‟s study showed hypersegmented neutrophils in all the patients. This study had same 
cut off value for MCV as our study.     
In other two studies there were lower percentage of hyper segmented neutrophils than our 
study, 25.5% in the study by Punia Bhatia and 43% in the study by Vineetha unnikrishnan et 
al.  
 
 
 
Our study  
n=50 
% 
Vineetha et al  
n=60 
% 
Macrocytosis with other features 
of megaloblastosis 
25 50 26 43 
Macrocytosis without other 
features of megaloblastosis 
25 50 34 57 
Table 30: Comparison of peripheral smear findings 
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In our study population of 50 patients 66% (n=33) underwent Upper GI scopy. 52% of the 
total study population had tropical sprue. Among them 58% patient had positive duodenal 
finding in the upper GI scopy and 42% does not have any positive finding in the duodenum. 
 
In comparison Pooja yadav et al showed Celiac disease as the commonest reason for (65%) 
mal-absorption following which was tropical sprue (22%).  The same study demonstrated that 
most patients with tropical sprue had normal duodenal Folds (85.7%) while, the appearance 
of duodenal folds was abnormal in 82% patients with celiac Disease. 
In another study conducted in north india by Ranjan P et al showed 39.3% of tropical sprue in 
their study population. 
 
 
Figure 35: Comparison of percentage of normal duodenal finding in tropical sprue 
42%
85.70%
Our study Pooja Yadev et al
percentage of normal duodenal finding in tropical sprue
Our study Pooja Yadev et al
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LIMITATIONS OF THE STUDY  
 
The following are the limitations of the study  
 
1. The study was done in a tertiary care hospital and only patients with macrocytic anemia   
were included. Henceforth, quite a few   number of patients with vitamin B12 and folate 
deficiency whom did not have anemia might have been missed. So the real prevalence of B12 
deficiency could not be identified from this study.  
 
2. In patients presented with nutritional deficiency complete work up of malabsorption like 
stool examination for ova and cyst, quantitative assay of stool fat, d-xylulose test, upper 
gastrointestinal endoscopy and biopsy was not done in all. 
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CONCLUSIONS AND RECOMMENDATIONS 
 Even though many diseases might lead to macrocytic anemia our study shows 
megaloblastic macrocytosis as the most common cause. 
 This demonstrates that megaloblastosis still remains the most significant reason for 
macrocytic anemia in our population which causes substantial morbidity. Low serum 
B12 vitamin was leading cause of megaloblastic anemia. 
 Considering megaloblastic anaemia as one of the differentials in pancytopenia is 
important.  
 Bleeding was not a presenting complaint in patients with thrombocytopenia due to 
B12 deficiency. 
 We observed in our study that being a non vegetarian does not protect against Vitamin 
B12 deficiency.  
 Although our study had very small number of cases with drug exposure, clinical 
history of drug intake is essential in evaluating for megaloblastic anemia. 
 Macro-ovalocytes and hyper-segmented neutrophils occurring in peripheral blood 
smear would  significantly favour  towards  diagnosing megaloblastic anemia. 
 The severity of anemia did not have any correlation with the levels of serum B12 or 
the degree of macrocytosis. 
 Upper GI endoscopy with deep duodenal biopsy should be done in all patients with 
megaloblastic anaemia. 
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 The prevalence of tropical sprue is also quite great. The high prevalence of tropical 
sprue as established in this study has not been revealed in any other study before. This 
emphasises the significance of evaluating tropical sprue in a suitable settings to the 
clinician.  
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                                                       APPENDIX  A 
 
PROFORMA 
Patient   ID :                     
Age :                         Sex:                        Occupation: 
Ip number : 
Date of admission: 
Presenting complaints: 
History : Thyroid disease/Drug intake/Alcohol consumption/vegetarian or non-vegetarian 
Clincal findings: Pallor/Icterus/skin hyperpigmentation/Organomegaly 
Investigations: 
Total count  ……………          Hemoglobin  …………….       Platelet count  ……………… 
MCV   …………………               RDW   …………….. 
Peripheral smear  ………….. 
Reticulocyte count  …………………….. 
Serum bilirubin ………………..   Direct bilirubin ………………   LDH  ……………. 
Vitamin B12 ………………        Folic acid …………. 
Bone marrow aspiration …………….. 
Bone marrow biopsy ……………… 
UGI scopy ……………… 
Duodenal biopsy  ……………….. 
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                                                                        Master Chart 1 
S.N
o 
Ag
e 
Sex Hemo
globi
n 
MCV Total 
Coun
t 
Platelet RDW Vita
min 
B12 
Folic 
Acid 
TSH Seru
m 
Biliru
bin 
Fatig
abilit
y 
Diarh
hoea 
Drug 
Expo
sure 
Veg/
NVeg 
Anem
ia 
Icter
us 
Hype
rpig
ment
ation 
Orga
nome
gali 
Peripheral Smear 
1 70 F 5.4 123.4 4500 294000 24.5 138 16.6 7.39 N Yes NO No NV Yes NO Yes NO Dimophic,Predominantly 
Macrocytic, Tear 
Drop,Elliptocytes,Speroc
ytes. 
2 36 M 8.9 112 3100 80000 15.2 30 12.3 1.81 N Yes NO No NV/A
LC 
Yes NO Yes NO Pancytopenia, 
Macrocytosis 
3 35 M 6.1 113 3300 8100 21.2 30 15.0
4 
# Y Yes NO No NV Yes Yes NO NO Macrocytic,Mild 
Leukopenia,Thrombocyt
openia,Elliptocytes,Poly
chromotophils 
4 65 F 6.7 137.5 9600 12700 23.7 40 # 0.85 N   Yes No NV Yes NO NO NO Macrocytic 
5 74 F 10.8 98.8 7900 279000 14.8 181 4.98 4.99 N Yes NO No NV Yes NO NO NO Macro 
6 45 F 7.5 107.8 3500 209000 21.1 135 11.9
2 
3.96 N Yes NO No NV Yes NO NO SPLE
EN 
Macro,Oval Macro,Tear 
Drop.Nrbc 
7 55 F 7.3 105.2 1660 140000 26.9 137 0.94 2.87 N NO Yes No NV Yes NO NO NO Macro And 
Micro,Hypersegmented,
Neutrophilsoval Macro, 
Tear Drop,Poly 
Chromoto 
8 62 M 7.2 110.9 7100 268000 20.8 76 2.79 0.05 N NO NO No V Yes NO NO NO Macro 
9 57 F 3.7 120.5 1400 48000 37.3 30 10.7 4.26 Y Yes NO No NV Yes Yes Yes NO Pancyto,Macro,Hyperseg
mented Neutrophils, 
Oval Macro, Tear 
Drop.Nrbc 
10 73 F 5.1 110.8 3200 154000 27.1 33 6.57 26.2 Y NO NO No NV Yes NO NO NO Macro,Tear Drop,Poly 
Chromo, 
11 55 M 5.8 110 3300 47000 17.5 55 # # N Yes Yes No NV/A
LC 
Yes NO Yes NO Macranisopoi,Polychrom
o,Nrbco 
12 18 M 7.1 127 3400 60000 22.2 997 9.28 # Y NO NO No V Yes NO NO NO Pan,Macro,Tear 
Drop,Poly Chromot,Nrbc 
13 57 F 10 109.4 8000 324000 18.7 122 5.59 6.52 Y Yes NO No NV Yes NO NO NO Macro 
14 71 M 11.1 113.8 1110 157000 20.7 62 11.2
9 
1.09 N NO NO No NV Yes NO NO NO Macro,Target,Sperocytes 
15 48 M 9.9 101 3600 143000   820 1.5 1.57 N NO NO No NV Yes NO NO NO Macro, 
16 25 F 6.1 119.5 12600 202000 16.7 79 7.14 4.49 N NO NO No NV Yes NO NO NO Macro,MACRO 
OVULOCYTES,HYPER
SEG NEUT, 
17 17 F 2.1 95.7 2700 15000 37 235 3.36 # N NO NO Yes NV Yes NO NO NO Aniso,Poi,Tear Drop 
18 75 F 8.2 98.3 8100 37600 23.2 30 11.4
8 
# N Yes NO No V Yes NO NO NO Macro 
19 45 M 7.1 113.3 2900 108000 18.7 50 20 3.03 Y Yes NO No V Yes NO NO NO Ovuloctes,Polychro,Tear 
Drop,Target 
20 87 M 8.3 127.3 11700 320000 18.2 576 2.31 # N NO NO No NV Yes NO NO NO Macro,Nrbc,Hyperseg 
Neutr 
21 54 M 12.9 104.3 6200 127000 16.5 132 9.38 # Y NO NO No NV/A
LC 
Yes Yes NO NO Poly Chr,Nrbc 
22 46 M 4.3 112.4 2600 29000 19.4 110 3.03 3.13 Y NO NO No NV/A
LC 
Yes Yes NO LIVE
R/SP
LEEN 
Macro,Oval Macro,Tear 
Drop,Nrbc,Hyperseg 
Neutro 
23 80 M 8.1 133.4 6500 212000 17.4 30 11.6
2 
75.8 N Yes NO No NV Yes NO Yes NO Macro,Ovalmacro,Polyc
hrom,Hyperseg 
24 48 F 10.9 112.7 10800 212000 16.4 120 3.2 6.8 N NO Yes No NV Yes NO NO NO Macro,Poly,Hyperseg 
25 54 M 6.6 114 4500 30000 24.9 113 6.93 1.75 N NO NO No V Yes NO NO NO Macro,Ovalmacro,Polyc
hrom,Hyperseg 
26 65 M 6.8 124.6 3900 48000 30.6 99 2.81 # N Yes NO No NV Yes NO NO NO Pan,Tear,Polychrom,Hyp
erseb,Nrbc 
27 55 M 8.5 110.5 5100 143000 26.5 161 14.6
8 
1.38 N Yes NO No NV Yes NO NO NO Macro,Macro 
Ovulocytes,Hyperseg 
Neut, 
28 58 M 4 124 2900 10000 21.8 84 4.3 2.44 N Yes Yes No NV Yes NO NO NO Pan,Macro,Nrbc 
#-not done 
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                                                   Master chart 1 continued 
29 70 M 5.2 112.9 2700 52000 25 67 15.7
5 
0.59 Y Yes NO No NV Yes Yes NO NO Pan,Oval 
Macr,Polychrom,Hypers
eg Neut 
30 45 M 5.8 109.9 2400 94000 17 224 5.39 2.23 N Yes NO No V Yes NO NO NO Pan,Ova,Tear,Polychro 
 
 
31 60 M 7.2 119.1 4100 154000 23.9 125 # 1.75 N Yes NO No NV Yes NO NO NO Dim,Predom Macro 
32 70 M 7.7 111.9 5400 51000 23.6 90 5.27 1.38 N NO NO No NV Yes NO NO NO Bicyt, 
33 24 M 11.3 124.8 5300 152000 18.4 111 # 1.6 N NO Yes No NV Yes NO NO NO Macro,Hyperseg Neut 
34 50 F 8.1 143.2 7900 366000 19.3 93 # 8.45 N NO Yes No NV Yes NO Yes NO Macro,Hyperseg Neut 
35 65 F 11.6 116.8 6700 277000 13 140 # 3.02 N NO NO No NV Yes NO NO NO Macrocytosis, 
36 70 M 4.6 114.3 2500 6400 20 936 # # Y Yes NO No NV Yes Yes Yes NO Pan,Oval 
Macr,Polychrom,Hypers
eg Neut 
37 72 M 10.5 115.4 2800 9500 16.4 142 1.62 # N NO NO No NV Yes NO NO NO Pancytopenia,  
38 36 F 2.2 115.7 6800 21000 38 91 >20 # N Yes NO No NV Yes NO NO NO Bicyto,Oval Macro,Poly 
Chr,Hyperseg Neut 
39 58 F 4.6 115.3 2400 70000 20.4 30 10.8
5 
# Y Yes NO No NV Yes Yes NO NO Pan,Polychr,Tear,Ellipto 
40 34 M 10.6 95.1 6400 344000 20.4 63 7.37 # Y Yes NO No NV/A
LC 
Yes NO NO NO Macro,Oval 
Macro,Poly,Target,Elipt
o,Nrbc 
41 48 M 5.9 110.8 3000 47000 38.8 50 # # N Yes NO Yes NV Yes NO Yes NO Pancytopenia 
42 51 M 8.9 109.7 2500 120000 19.5 60 # 1.65 N NO Yes No NV Yes NO NO NO Pancytopenia 
43 40 M 3.5 117.1 4600 59000 20.8 32 # 2.24 Y Yes NO No NV Yes NO NO NO Macro,Poly,Hyperseg,Nr
bc,Ellipto 
44 20 M 4.7 129.3 7200 172000 23.4 219 10.6
3 
# Y Yes NO Yes NV Yes Yes NO NO Macro,Tear Drop,Poly 
Chromo,Nrbc, 
45 58 M 6.4 132.6 4300 151000 25.4 50            
>20 
2.58 Y Yes NO No NV Yes Yes NO NO Macro,Macro 
Ovulocytes,Hyperseg 
Neut,Nrbc, 
46 51 M 5 99.7 2800 43000 29.2 55 4.53 6.64 Y Yes NO No NV Yes NO NO NO Pan,Mac,Macro 
Ovulo,Ellipto 
47 63 M 4.6 113.9 3200 43000 20 88 6.85 4.68 N Yes NO No NV Yes NO NO NO Pan,Mac,Macro 
Ovulo,Ellipto,Hyperseg,
Polychrom 
48 60 M 7.2 121 3000 72000 23 52 9.87 # N Yes NO No NV Yes NO NO NO Tear,Pan,Tar 
49 59 M 5.5 108.5 4500 101000 36.3 105 13.2
5 
1.7 N Yes NO No NV Yes NO NO NO Macro,Oval 
Macro,Polychrom, 
50 43 M 7.6 127 3100 62000 20.1 53 9.7 1.24 Y Yes NO No NV Yes Yes NO NO Pan,Mac,Macro 
Ovulocy,Hyperseg 
#-Not done 
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Master Chart 2 
S.NO A
G
E 
S
E
X 
UGI SCOPY DUODENAL 
BIOPSY 
BONE MARROW 
ASPIRATION 
BONE MARROW BIOPSY 
1 70 F EROSIVE GASTRITIS INTRA 
EPITHELIAL 
LYMPHOCYTOSIS 
ERYTHROID 
HYPERPLASIA,MILD 
MEGALOBLASTIC 
ERYTHROID 
HYPERPLASIA, 
NORMOBLASTIC 
MATURATION 
2 36 M GASTRIC POLYP TROPICAL 
SPRUE/ENDOCRI
NE 
MEGALOBLASTIC,INEFF
ECTIVE ERYTHROPOESIS 
MEGALOBLASTIC 
3 35 M SCALLOPED 
DUODENAL FOLDS 
TROPICAL SPRUE # # 
4 65 F SCALL D2 TROPICAL SPRUE DIMORPHIC,PREDOMINA
NT MEGALOBLASTIC 
# 
5 74 F SCALLOPED 
DUODENAL FOLDS 
NONSPECIFIC 
CHRONIC 
DUODENITIS 
# # 
6 45 F EROSIVE GASTRITIS BRUNNER 
GLAND 
HYPERPLASIA 
# # 
7 55 F #   # # 
8 62 M SCALLOPED 
DUODENAL FOLDS 
NO SPECIFIC 
PATHOLOGY 
# # 
9 57 F FLATTENED 
DUODENAL FOLDS 
NO SPECIFIC 
PATHOLOGY 
MEGALOBLASTIC ERYTHROID 
HYPERPLASIA, 
NOEMOBLASTIC 
MATURATION 
10 73 F ATROPHIC 
GASTRIRIS 
NO SPECIFIC 
PATHOLOGY 
# # 
11 55 M SCALLOPED 
DUODENAL FOLDS 
TROPICAL SPRUE HYPERCELLULAR,MEGA
LOBLASTIC 
MEGALOBLASTIC 
12 18 M SCALLOPED 
DUODENAL FOLDS 
NO SPECIFIC 
PATHOLOGY 
MEGALOBLASTIC MEGALOBLASTIC 
ERYTHROID HYPERPLASIA 
13 57 F #   # # 
14 71 M #   # # 
15 48 M #   # # 
16 25 F SCALLOPED 
DUODENAL FOLDS 
TROPICAL SPRUE MEGALOBLASTIC 
ANEMIA WITH 
INEFFECTIVE 
ERYTHROPOESIS 
ERYTHROID 
HYPERPLASIA, 
MEGALOBLASTIC 
MATURATION 
17 17 F #   MEGALOBLASTIC MEGALOBLASTIC 
18 75 F #   # # 
19 45 M SCALLOPED AND 
FLATTENED  
NONSPECIFIC 
CHRONIC  
# # 
20 87 M #   # # 
21 54 M #   # # 
22 46 M #   MEGALOBLASTIC 
ANEMIA 
ERYTHROID HYPERPLASIA 
23 80 M SCALLOPED 
DUODENAL FOLDS 
CHRONIC 
DUODENITIS   
# # 
24 48 F #   # # 
    #-not done                                                   
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Master chart  2 continued 
25 54 M #   # # 
26 65 M SCALLOPED 
DUODENAL FOLDS 
TROPICAL SPRUE # # 
27 55 M #   # # 
28 58 M SCALLOPED 
DUODENAL FOLDS 
TROPICAL SPRUE # HYPERCELLULAR 
MARROW WITH  
29 70 M ATROPHIC 
GASTRIRIS 
NO SPECIFIC 
PATHOLOGY 
# # 
30 45 M SCALLOPED 
DUODENAL FOLDS 
TROPICAL SPRUE MEGALOBLASTIC 
ANEMIA 
MEGALOBLASTIC ANEMIA 
31 60 M #   MEGALOBLASTIC 
ANEMIA 
# 
32 70 M SCALLOPED 
DUODENAL FOLDS 
TROPICAL SPRUE MEGALOBLASTIC 
ERYTHROID 
HYPERPLASIA 
HYPERCELLULAR 
MARROW WITH 
MEGALOBLASTIC  
33 24 M SCALLOPED 
DUODENAL FOLDS 
TROPICAL SPRUE MEGALOBLASTIC 
ANEMIA 
# 
34 50 F SCALLOPED 
DUODENAL FOLDS 
INTRA 
EPITHELIAL 
LYMPHOCYTOSIS 
MEGALOBLASTIC 
ANEMIA 
# 
35 65 F SCALLOPED 
DUODENAL FOLDS 
TROPICAL SPRUE MEGALOBLASTIC 
ERYTHROID 
HYPERPLASIA 
# 
36 70 M FLATTENED 
DUODENAL FOLDS 
peptic duodinitis MEGALOBLASTIC 
ANEMIA WITH  
# 
37 72 M #   MEGALOBLASTIC 
ANEMIA 
MEGALOBLASTIC ANEMIA 
38 36 F #   MEGALOBLASTIC 
ANEMIA WITH  
MEGALOBLASTIC ANEMIA 
39 58 F SCALLOPED 
DUODENAL FOLDS 
TROPICAL SPRUE MEGALOBLASTIC 
ANEMIA 
MEGALOBLASTIC ANEMIA 
40 34 M EXTRENSIC 
IMPRESSION BODY  
TROPICAL SPRUE # # 
41 48 M SCALLOPED 
DUODENAL FOLDS 
TROPICAL SPRUE MEGALOBLASTIC 
ANEMIA 
HYPERCELLULAR  
HYPERPLASIA 
42 51 M #   MEGALOBLASTIC 
ANEMIA 
# 
43 40 M FLATTENED 
DUODENAL FOLDS 
TROPICAL SPRUE MEGALOBLASTIC 
ANEMIA 
MEGALOBLASTIC ANEMIA 
44 20 M FLATTENED 
DUODENAL FOLDS 
NO SPECIFIC 
PATHOLOGY 
MEGALOBLASTIC 
ERYTHROID  
# 
45 58 M ANTRAL GASTRITIS NEURO  MEGALOBLASTIC 
ANEMIA 
MEGALOBLASTIC ANEMIA 
46 51 M # # DIMORPHIC ANEMIA DIMORPHIC ANEMIA 
47 63 M SCALLOPED 
DUODENAL FOLDS 
TROPICAL SPRUE MEGALOBLASTIC 
ANEMIA 
# 
48 60 M SCALLOPED 
DUODENAL FOLDS 
NONSPECIFIC 
CHRONIC 
DUODENITIS 
MEGALOBLASTIC 
ANEMIA 
MEGALOBLASTIC ANEMIA 
49 59 M SCALLOPED 
DUODENAL FOLDS 
BRUNNER 
GLAND 
HYPERPLASIA 
MEGALOBLASTIC 
ANEMIA 
# 
50 43 M FLATTENED 
DUODENAL FOLDS 
TROPICAL SPRUE MEGALOBLASTIC 
ERYTHROID 
HYPERPLASIA 
MEGALOBLASTIC 
ERYTHROID HYPERPLASIA 
 
 
 
# - Not done 
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